{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "antiviral activities", "drug discovery", "medicinal plants", "natural therapeutics/alternative medicine", "secondary metabolites"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32850918", "DateRevised": {"Year": "2023", "Month": "11", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "08", "Day": "07"}], "Language": ["eng"], "ELocationID": ["444", "10.3389/fmed.2020.00444"], "Journal": {"ISSN": "2296-858X", "JournalIssue": {"Volume": "7", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in medicine", "ISOAbbreviation": "Front Med (Lausanne)"}, "ArticleTitle": "Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic.", "Pagination": {"StartPage": "444", "MedlinePgn": "444"}, "Abstract": {"AbstractText": ["COVID-19, a disease induced by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2), has been the cause of a worldwide pandemic. Though extensive research works have been reported in recent days on the development of effective therapeutics against this global health crisis, there is still no approved therapy against SARS-CoV-2. In the present study, plant-synthesized secondary metabolites (PSMs) have been prioritized to make a review focusing on the efficacy of plant-originated therapeutics for the treatment of COVID-19. Plant metabolites are a source of countless medicinal compounds, while the diversity of multidimensional chemical structures has made them superior to treat serious diseases. Some have already been reported as promising alternative medicines and lead compounds for drug repurposing and discovery. The versatility of secondary metabolites may provide novel antibiotics to tackle MDR (Multi-Drug Resistant) microbes too. This review attempted to find out plant metabolites that have the therapeutic potential to treat a wide range of viral pathogens. The study includes the search of remedies belonging to plant families, susceptible viral candidates, antiviral assays, and the mode of therapeutic action; this attempt resulted in the collection of an enormous number of natural therapeutics that might be suggested for the treatment of COVID-19. About 219 plants from 83 families were found to have antiviral activity. Among them, 149 plants from 71 families were screened for the identification of the major plant secondary metabolites (PSMs) that might be effective for this pandemic. Our investigation revealed that the proposed plant metabolites can serve as potential anti- SARS-CoV-2 lead molecules for further optimization and drug development processes to combat COVID-19 and future pandemics caused by viruses. This review will stimulate further analysis by the scientific community and boost antiviral plant-based research followed by novel drug designing."], "CopyrightInformation": "Copyright \u00a9 2020 Bhuiyan, Howlader, Raihan and Hasan."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, University of Chittagong, Chittagong, Bangladesh."}, {"Identifier": [], "Affiliation": "Laboratory of Biotechnology and Molecular Biology, Department of Botany, University of Chittagong, Chittagong, Bangladesh."}], "LastName": "Bhuiyan", "ForeName": "Farhana Rumzum", "Initials": "FR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Chemistry and Chemical Engineering, University of Chittagong, Chittagong, Bangladesh."}], "LastName": "Howlader", "ForeName": "Sabbir", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering and Biotechnology, Shahjalal University of Science and Technology, Sylhet, Bangladesh."}], "LastName": "Raihan", "ForeName": "Topu", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceuticals and Industrial Biotechnology, Sylhet Agricultural University, Sylhet, Bangladesh."}], "LastName": "Hasan", "ForeName": "Mahmudul", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Med (Lausanne)", "NlmUniqueID": "101648047", "ISSNLinking": "2296-858X"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Brian DA, Baric RS. Coronavirus genome structure and replication. Curr Top Microbiol Immunol. (2005) 287:1\u201330. 10.1007/3-540-26765-4_1", "ArticleIdList": ["10.1007/3-540-26765-4_1", "PMC7120446", "15609507"]}, {"Citation": "Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. (2020) 395:565\u201374. 10.1016/S0140-6736(20)30251-8", "ArticleIdList": ["10.1016/S0140-6736(20)30251-8", "PMC7159086", "32007145"]}, {"Citation": "Cavanagh D. Coronavirus avian infectious bronchitis virus. Vet Res. (2007) 38:281\u201397. 10.1051/vetres:2006055", "ArticleIdList": ["10.1051/vetres:2006055", "17296157"]}, {"Citation": "Ismail MM, Tang Y, Saif YM. Pathogenicity of turkey coronavirus in turkeys and chickens. Avian Dis. (2003) 47:515\u201322. 10.1637/5917", "ArticleIdList": ["10.1637/5917", "14562877"]}, {"Citation": "Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. (2015) 1282:1\u201323. 10.1007/978-1-4939-2438-7_1", "ArticleIdList": ["10.1007/978-1-4939-2438-7_1", "PMC4369385", "25720466"]}, {"Citation": "Lan Jun, Jiwan Ge, Jinfang Yu, Sisi Shan, Huan Zhou, et al. . Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. (2020) 581:215\u201320 10.1101/2020.02.19.956235", "ArticleIdList": ["10.1101/2020.02.19.956235", "32225176"]}, {"Citation": "Chen Y, Peng H, Wang L, Zhao Y, Zeng L, Gao H, et al. . Infants born to mothers with a new coronavirus (COVID-19). Front Pediatr. (2020) 8:104. 10.3389/fped.2020.00104", "ArticleIdList": ["10.3389/fped.2020.00104", "PMC7098456", "32266184"]}, {"Citation": "WHO \nDirector-General's Opening Remarks at the Media Briefing on COVID-19. (2020). Available online at: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19 (accessed May 15, 2020)."}, {"Citation": "WHO \nDirector-General's Opening Remarks at the Media Briefing on COVID-19. (2020). Available online at: https://www.who.int/dg/speeches/detail/who-director-general-sopening-remarks-at-the-media-briefing-on-covid-19 (accessed April 5, 2020)."}, {"Citation": "Kanne JP. Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: Key points for the radiologist. Radiology. (2020) 295:16\u20137. 10.1148/radiol.2020200241", "ArticleIdList": ["10.1148/radiol.2020200241", "PMC7233362", "32017662"]}, {"Citation": "Zumla A, Chan JFW, Azhar EI, Hui DSC, Yuen KY. Coronaviruses-drug discovery and therapeutic options. Nat Rev Drug Discov. (2016) 15:327\u201347. 10.1038/nrd.2015.37", "ArticleIdList": ["10.1038/nrd.2015.37", "PMC7097181", "26868298"]}, {"Citation": "Heymann DL, Rodier G. Global surveillance, national surveillance, and SARS. Emerg Infect Dis. (2004) 10:173\u20135. 10.3201/eid1002.031038", "ArticleIdList": ["10.3201/eid1002.031038", "PMC3322938", "15040346"]}, {"Citation": "Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. (2012) 367:1814\u201320. 10.1056/NEJMoa1211721", "ArticleIdList": ["10.1056/NEJMoa1211721", "23075143"]}, {"Citation": "Shetty R, Ghosh A, Honavar SG, Khamar P, Sethu S. Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: present and future. Indian J Ophthalmol. (2020) 68:693\u2013702. 10.4103/ijo.IJO_639_20", "ArticleIdList": ["10.4103/ijo.IJO_639_20", "PMC7350468", "32317431"]}, {"Citation": "Hirano T, Murakami M. COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity. (2020) 52:731\u20133. 10.1016/j.immuni.2020.04.003", "ArticleIdList": ["10.1016/j.immuni.2020.04.003", "PMC7175868", "32325025"]}, {"Citation": "Pedersen SF, Ho YC. SARS-CoV-2: a storm is raging. J Clin Invest. (2020) 130:2202\u20135. 10.1172/JCI137647", "ArticleIdList": ["10.1172/JCI137647", "PMC7190904", "32217834"]}, {"Citation": "Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. (2020) 53:25\u201332. 10.1016/j.cytogfr.2020.05.003", "ArticleIdList": ["10.1016/j.cytogfr.2020.05.003", "PMC7211650", "32446778"]}, {"Citation": "Moses T, Goossens A. Plants for human health: greening biotechnology and synthetic biology. J Exp Bot. (2017) 68:4009\u201311. 10.1093/jxb/erx268", "ArticleIdList": ["10.1093/jxb/erx268", "PMC5853463", "28922776"]}, {"Citation": "Schaal B. Plants and people: our shared history and future. Plants People Planet. (2019) 1:14\u20139. 10.1002/ppp3.12", "ArticleIdList": ["10.1002/ppp3.12"]}, {"Citation": "World Health Organization WHO Global Report on Traditional and Complementary Medicine 2019. World Health Organization; (2019)."}, {"Citation": "Hoque Haque MI, Chowdhury ABMA, Shahjahan M, Harun MGD. Traditional healing practices in rural Bangladesh: a qualitative investigation. BMC Complement Altern Med. (2018) 18:62. 10.1186/s12906-018-2129-5", "ArticleIdList": ["10.1186/s12906-018-2129-5", "PMC5815193", "29448941"]}, {"Citation": "Ozioma E, Okaka A. Herbal medicines in African traditional medicine. In: Ozioma EJ, Chinwe OAN. editors. Herbal Medicine. Intratech open; (2019). p. 1\u201325."}, {"Citation": "Jassim SAA, Naji MA. Novel antiviral agents: a medicinal plant perspective. J Appl Microbiol. (2003) 95:412\u201327. 10.1046/j.1365-2672.2003.02026.x", "ArticleIdList": ["10.1046/j.1365-2672.2003.02026.x", "12911688"]}, {"Citation": "Hussain W, Haleem KS, Khan I, Tauseef I, Qayyum S, Ahmed B, et al. Medicinal plants: a repository of antiviral metabolites. Future Virol. (2017) 12:299\u2013308. 10.2217/fvl-2016-0110", "ArticleIdList": ["10.2217/fvl-2016-0110"]}, {"Citation": "\u00d6z\u00e7elik B, Kartal M, Orhan I. Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids. Pharm Biol. (2011) 49:396\u2013402. 10.3109/13880209.2010.519390", "ArticleIdList": ["10.3109/13880209.2010.519390", "21391841"]}, {"Citation": "Pick A, Ling K, Khoo BF, Seah CH, Foo KY, Cheah RK. Inhibitory activities of methanol extracts of Andrographis Paniculata and Ocimum Sanctum against Dengue-1 virus. In: International Conference on Biological, Environment & Food Engineering. Bali: (2014). p. 6."}, {"Citation": "Namazi R, Zabihollahi R, Behbahani M, Rezae A. Inhibitory activity of Avicennia marina, a medicinal plant in persian folk medicine, against HIV and HSV. Iran J Pharm Res.. (2013) 12:435\u201343.", "ArticleIdList": ["PMC3813244", "24250619"]}, {"Citation": "Zhou B, Yang Z, Feng Q, Liang X, Li J, Zanin M, et al. . Aurantiamide acetate from baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-\u03baB signaling pathway in influenza A virus-infected cells. J Ethnopharmacol. (2017) 199:60\u20137. 10.1016/j.jep.2017.01.038", "ArticleIdList": ["10.1016/j.jep.2017.01.038", "28119097"]}, {"Citation": "Castillo-Maldonado I, Moreno-Altamirano MMB, Serrano-Gallardo LB. Anti-dengue serotype-2 activity effect of Sambucus nigra leaves-and flowers-derived compounds. Virol Res Rev. (2017) 1:1\u20135. 10.15761/VRR.1000117", "ArticleIdList": ["10.15761/VRR.1000117"]}, {"Citation": "Chen C, Zuckerman DM, Brantley S, Sharpe M, Childress K, Hoiczyk E, et al. . Sambucus nigra extracts inhibit infectious bronchitis virus at an early point during replication. BMC Vet Res. (2014) 10:24. 10.1186/1746-6148-10-24", "ArticleIdList": ["10.1186/1746-6148-10-24", "PMC3899428", "24433341"]}, {"Citation": "Andleeb R, Ashraf A, Muzammil S, Naz S, Asad F, Ali T, et al. . Analysis of bioactive composites and antiviral activity of Iresine herbstii extracts against Newcastle disease virus in ovo. Saudi J Biol Sci. (2020) 27:335\u201340. 10.1016/j.sjbs.2019.10.002", "ArticleIdList": ["10.1016/j.sjbs.2019.10.002", "PMC6933243", "31889855"]}, {"Citation": "Szl\u03bcvik L, Min\u03bcrovits J, Forgo P. Alkaloids from Leucojum vernum and antiretroviral activity of Amaryllidaceae alkaloids. Planta Medica. (2004) 70:871\u20133. 10.1055/s-2004-827239", "ArticleIdList": ["10.1055/s-2004-827239", "15386196"]}, {"Citation": "Lopes RC, Oliveira DB, Costa SS, Miranda MMFS, Romanos MT V, Santos NSO, et al. . In vitro anti-rotavirus activity of some medicinal plants used in Brazil against diarrhea. J Ethnopharmacol. (2005) 99:403\u20137. 10.1016/j.jep.2005.01.032", "ArticleIdList": ["10.1016/j.jep.2005.01.032", "15876501"]}, {"Citation": "Reichling J, Neuner A, Sharaf M, Harkenthal M, Schnitzler P. Antiviral activity of Rhus aromatica (fragrant sumac) extract against two types of herpes simplex viruses in cell culture. Pharmazie. (2009) 64:538\u201341.", "ArticleIdList": ["19746844"]}, {"Citation": "Modi M, Nutan, Pancholi B, Kulshrestha S, Rawat AKS, Malhotra S, et al. . Anti-HIV-1 activity, protease inhibition and safety profile of extracts prepared from Rhus parviflora. BMC Complement Altern Med. (2013) 13:158. 10.1186/1472-6882-13-158", "ArticleIdList": ["10.1186/1472-6882-13-158", "PMC3716979", "24059266"]}, {"Citation": "Nocchi SR, Companhoni MVP, De Mello JCP, Dias Filho BP, Nakamura CV, Carollo CA, et al. . Antiviral activity of crude hydroethanolic extract from Schinus terebinthifolia against herpes simplex virus type 1. Planta Med. (2017) 83:509\u201318. 10.1055/s-0042-117774", "ArticleIdList": ["10.1055/s-0042-117774", "27706530"]}, {"Citation": "Park JY, Ko JA, Kim DW, Kim YM, Kwon HJ, Jeong HJ, et al. . Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J Enzyme Inhib Med Chem. (2016) 31:23\u201330. 10.3109/14756366.2014.1003215", "ArticleIdList": ["10.3109/14756366.2014.1003215", "25683083"]}, {"Citation": "Tolo FM, Rukunga GM, Muli FW, Njagi ENM, Njue W, Kumon K, et al. . Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against Herpes simplex virus. J Ethnopharmacol. (2006) 104:92\u20139. 10.1016/j.jep.2005.08.053", "ArticleIdList": ["10.1016/j.jep.2005.08.053", "16198524"]}, {"Citation": "Bonvicini F, Lianza M, Mandrone M, Poli F, Gentilomi GA, Antognoni F. Hemidesmus indicus (L.) R. Br. Extract inhibits the early step of herpes simplex type 1 and type 2 replication. New Microbiol. (2018) 41:187\u201394.", "ArticleIdList": ["29874387"]}, {"Citation": "Ritt\u00e0 M, Marengo A, Civra A, Lembo D, Cagliero C, Kant K, et al. . Antiviral activity of a Arisaema tortuosum leaf extract and some of its constituents against herpes simplex virus type 2. Planta Med. (2020) 86:267\u201375. 10.1055/a-1087-8303", "ArticleIdList": ["10.1055/a-1087-8303", "31968380"]}, {"Citation": "Lee JS, Ko E, Hwang HYESUK, Lee Y, Kwon Y, Kim M, et al. . Antiviral activity of ginseng extract against respiratory syncytial virus infection. Int J Mol Med. (2014) 34:183\u201390. 10.3892/ijmm.2014.1750", "ArticleIdList": ["10.3892/ijmm.2014.1750", "PMC4072342", "24756136"]}, {"Citation": "Lee MH, Lee B, Jung J, Cheon D, Kim K, Choi C. Antiviral effect of Korean red ginseng extract and ginsenosides on murine norovirus and feline calicivirus as surrogates for human norovirus. J Ginseng Res. (2011) 35:429\u201335. 10.5142/jgr.2011.35.4.429", "ArticleIdList": ["10.5142/jgr.2011.35.4.429", "PMC3659551", "23717088"]}, {"Citation": "Choi J, Jin Y, Lee H, Oh TW, Yim N, Cho W. Protective effect of Panax notoginseng root water extract against influenza a virus infection by enhancing antiviral interferon-mediated immune responses and natural killer cell activity. Front Immunol. (2017) 8:1542. 10.3389/fimmu.2017.01542", "ArticleIdList": ["10.3389/fimmu.2017.01542", "PMC5693858", "29181006"]}, {"Citation": "Glatthaar-Saalm\u00fcller B, Fal AM, Sch\u00f6nknecht K, Conrad F, Sievers H, Saalm\u00fcller A. Antiviral activity of an aqueous extract derived from Aloe arborescens Mill. against a broad panel of viruses causing infections of the upper respiratory tract. Phytomedicine. (2015) 22:911\u201320. 10.1016/j.phymed.2015.06.006", "ArticleIdList": ["10.1016/j.phymed.2015.06.006", "PMC7127631", "26321740"]}, {"Citation": "Zandi K, Zadeh MA, Sartavi K, Rastian Z. Antiviral activity of Aloe vera against herpes simplex virus type 2 : an in vitro study. Afr J Biotechnol. (2007) 6:1770203 10.5897/AJB2007.000-2276", "ArticleIdList": ["10.5897/AJB2007.000-2276"]}, {"Citation": "Moradi M, Rafieian-kopaei M, Karimi A. A review study on the effect of Iranian herbal medicines against in vitro replication of herpes simplex virus. Avicenna J Phytomed. (2016) 6:506\u201315.", "ArticleIdList": ["PMC5052413", "27761420"]}, {"Citation": "Soltan MM, Zaki AK. Antiviral screening of forty-two Egyptian medicinal plants. J Ethnopharmacol. (2009) 126:102\u20137. 10.1016/j.jep.2009.08.001", "ArticleIdList": ["10.1016/j.jep.2009.08.001", "19666102"]}, {"Citation": "Patocka J, Navratilova Z. Achillea fragrantissima : pharmacology review. Clin Oncol. (2019) 4:1601."}, {"Citation": "Visintini M, Redko F, Muschietti L, Campos R, Martino V, Cavallaro LV. in vitro antiviral activity of plant extracts from Asteraceae medicinal plants. Virol J. (2013) 10:245. 10.1186/1743-422X-10-245", "ArticleIdList": ["10.1186/1743-422X-10-245", "PMC3733733", "23890410"]}, {"Citation": "Derksen A, K\u00fchn J, Hafezi W, Sendker J, Ehrhardt C, Ludwig S, et al. . Antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virus. J Ethnopharmacol. (2016) 188:144\u201352. 10.1016/j.jep.2016.05.016", "ArticleIdList": ["10.1016/j.jep.2016.05.016", "27178637"]}, {"Citation": "Lani R, Hassandarvish P, Chiam CW, Moghaddam E, Chu JJH, Rausalu K, et al. . Antiviral activity of silymarin against chikungunya virus. Sci Rep. (2015) 5:11421. 10.1038/srep11421", "ArticleIdList": ["10.1038/srep11421", "PMC4468427", "26078201"]}, {"Citation": "Benassi-Zanqueta \u00c9, Marques CF, Valone LM, Pellegrini BL, Bauermeister A, Ferreira ICP, et al. . Evaluation of anti-HSV-1 activity and toxicity of hydroethanolic extract of Tanacetum parthenium (L.) Sch.Bip. (Asteraceae). Phytomedicine. (2019) 55:249\u201354. 10.1016/j.phymed.2018.06.040", "ArticleIdList": ["10.1016/j.phymed.2018.06.040", "30668436"]}, {"Citation": "Rehman S, Ijaz B, Fatima N, Aun S. Sciencedirect therapeutic potential of Taraxacum officinale against HCV NS5B polymerase : in-vitro and in silico study. Biomed Pharmacother. (2016) 83:881\u201391. 10.1016/j.biopha.2016.08.002", "ArticleIdList": ["10.1016/j.biopha.2016.08.002", "27513212"]}, {"Citation": "He W, Han H, Wang W, Gao B. Anti-influenza virus effect of aqueous extracts from dandelion. Virol J. (2011) 8:538. 10.1186/1743-422X-8-538", "ArticleIdList": ["10.1186/1743-422X-8-538", "PMC3265450", "22168277"]}, {"Citation": "Rothan HA, Zulqarnain M, Ammar YA, Tan EC, Rahman NA, Yusof R. Screening of antiviral activities in medicinal plants extracts against dengue virus using dengue NS2B-NS3 protease assay. Trop Biomed. (2014) 31:286\u201396.", "ArticleIdList": ["25134897"]}, {"Citation": "Mgole S, Pieters L, David O, Apers S, Vingerhoets R, Cos P, et al. . Screening of some Tanzanian medicinal plants from Bunda District for antibacterial, antifungal and antiviral activities. J Ethnopharmacol. (2008) 119:58\u201366. 10.1016/j.jep.2008.05.033", "ArticleIdList": ["10.1016/j.jep.2008.05.033", "18582554"]}, {"Citation": "Al-thobaiti SA, Zeid IMA. Phytochemistry and pharmaceutical evaluation of Balanites aegyptiaca : an overview. J Exp Biol Agric Sci. (2018) 6:453\u201365 10.18006/2018.6(3).453.465", "ArticleIdList": ["10.18006/2018.6(3).453.465"]}, {"Citation": "Cho WK, Kim H, Choi YJ, Yim NH, Yang HJ, Ma JY. Epimedium koreanum Nakai water extract exhibits antiviral activity against porcine epidermic diarrhea virus in vitro and in vivo. Evid Based Complement Altern Med. (2012) 2012:985150. 10.1155/2012/985151", "ArticleIdList": ["10.1155/2012/985151", "PMC3521454", "23259003"]}, {"Citation": "Park JY, Jeong HJ, Kim JH, Kim YM, Park SJ, Kim D, et al. . Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biol Pharm Bull. (2012) 35:2036\u201342. 10.1248/bpb.b12-00623", "ArticleIdList": ["10.1248/bpb.b12-00623", "22971649"]}, {"Citation": "Tung NH, Kwon HJ, Kim JH, Ra JC, Ding Y, Kim JA, et al. . Anti-influenza diarylheptanoids from the bark of Alnus japonica. Bioorganic Med Chem Lett. (2010) 20:1000\u20133. 10.1016/j.bmcl.2009.12.057", "ArticleIdList": ["10.1016/j.bmcl.2009.12.057", "20045319"]}, {"Citation": "Lin CW, Tsai FJ, Tsai CH, Lai CC, Wan L, Ho TY, et al. . Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res. (2005) 68:36\u201342. 10.1016/j.antiviral.2005.07.002", "ArticleIdList": ["10.1016/j.antiviral.2005.07.002", "PMC7114321", "16115693"]}, {"Citation": "Chen F, Yang L, Huang Y, Chen Y, Sang H, Duan W, et al. . Isocorilagin, isolated from Canarium album (Lour.) Raeusch, as a potent neuraminidase inhibitor against influenza A virus. Biochem Biophys Res Commun. (2020) 523:183\u20139. 10.1016/j.bbrc.2019.12.043", "ArticleIdList": ["10.1016/j.bbrc.2019.12.043", "31843192"]}, {"Citation": "C\u00e9sar GZJ, Alfonso MGG, Marius MM, Elizabeth EM, \u00c1ngel CBM, Maira HR, Guadalupe CLM, et al. . Inhibition of HIV-1 reverse transcriptase, toxicological and chemical profile of Calophyllum brasiliense extracts from Chiapas, Mexico. Fitoterapia. (2011) 82:1027\u201334. 10.1016/j.fitote.2011.06.006", "ArticleIdList": ["10.1016/j.fitote.2011.06.006", "21723379"]}, {"Citation": "Ibrahim AK, Youssef AI, Arafa AS, Ahmed SA. Anti-H5N1 virus flavonoids from Capparis sinaica Veill. Nat Prod Res. (2013) 27:2149\u201353. 10.1080/14786419.2013.790027", "ArticleIdList": ["10.1080/14786419.2013.790027", "23651316"]}, {"Citation": "Ghazal EA, Khamis IMA, Elhaw MHM. Chemical constituents of Capparis sinaica Veill. plant and its antimicrobial effects. Middle East J Appl Sci. (2015) 5:411\u201322."}, {"Citation": "Lam S-Z, Ng T-B. A protein with antiproliferative, antifungal and HIV-1 reverse transcriptase inhibitory activities from caper (Capparis spinosa) seeds. Phytomedicine. (2009) 16:444\u201350. 10.1016/j.phymed.2008.09.006", "ArticleIdList": ["10.1016/j.phymed.2008.09.006", "19019643"]}, {"Citation": "Callies O, Bedoya LM, Beltra M, Mun A, Obrego P, Osorio AA, et al. . Isolation, structural modification, and HIV inhibition of pentacyclic lupane-type triterpenoids from Cassine xylocarpa and Maytenus cuzcoina. J Nat Prod. (2015) 78:1045\u201355. 10.1021/np501025r", "ArticleIdList": ["10.1021/np501025r", "25927586"]}, {"Citation": "Inoue R. Orally administered Salacia reticulata extract reduces h1n1 influenza clinical symptoms in murine lung tissues putatively due to enhanced natural killer cell activity. Front Immunol. (2016) 7:115. 10.3389/fimmu.2016.00115", "ArticleIdList": ["10.3389/fimmu.2016.00115", "PMC4814808", "27066007"]}, {"Citation": "Rebensburg S, Helfer M, Schneider M, Koppensteiner H, Eberle J, Schindler M, et al. . Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins. Sci Rep. (2016) 6:20394. 10.1038/srep20394", "ArticleIdList": ["10.1038/srep20394", "PMC4735868", "26833261"]}, {"Citation": "Javed T, Ashfaq UA, Riaz S, Rehman S, Riazuddin S. In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus. Virol J. (2011) 8:26. 10.1186/1743-422X-8-26", "ArticleIdList": ["10.1186/1743-422X-8-26", "PMC3032714", "21247464"]}, {"Citation": "Alcami J, Bermejo P. Phytomedicine Ellagitannins from Tuberaria lignosa as entry inhibitors of HIV. Phytomedicine. (2010) 17:69\u201374. 10.1016/j.phymed.2009.08.008", "ArticleIdList": ["10.1016/j.phymed.2009.08.008", "19748255"]}, {"Citation": "Mushi NF, Mbwambo ZH, Innocent E, Tewtrakul S. Activities of aqueous ethanolic extracts from Combretum adenogonium Steud. Ex A. Rich (Combretaceae). BMC Complement Altern Med. (2012) 12:163. 10.1186/1472-6882-12-163", "ArticleIdList": ["10.1186/1472-6882-12-163", "PMC3517472", "23013240"]}, {"Citation": "Liu M, Katerere DR, Gray AI, Seidel V. Phytochemical and antifungal studies on Terminalia mollis and Terminalia brachystemma. Fitoterapia. (2009) 80:369\u201373. 10.1016/j.fitote.2009.05.006", "ArticleIdList": ["10.1016/j.fitote.2009.05.006", "19446614"]}, {"Citation": "Lavoie S, C\u00f4t\u00e9 I, Pichette A, Gauthier C, Ouellet M, Nagau-Lavoie F, et al. . Chemical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extracts from Cornus canadensis. BMC Complement Altern Med. (2017) 17:2. 10.1186/s12906-017-1618-2", "ArticleIdList": ["10.1186/s12906-017-1618-2", "PMC5322616", "28228101"]}, {"Citation": "Hsieh CF, Chen YL, Lin CF, Ho JY, Huang CH, Chiu CH, et al. . An extract from Taxodium distichum targets hemagglutinin- and neuraminidase-related activities of influenza virus in vitro. Sci Rep. (2016) 6:36015. 10.1038/srep36015", "ArticleIdList": ["10.1038/srep36015", "PMC5086851", "27796330"]}, {"Citation": "Xu H, Ma Y, Huang X, Geng C, Wang H. Bioactivity-guided isolation of anti-hepatitis B virus active sesquiterpenoids from the traditional Chinese medicine : Rhizomes of Cyperus rotundus. J Ethnopharmacol. (2015) 171:131\u201340. 10.1016/j.jep.2015.05.040", "ArticleIdList": ["10.1016/j.jep.2015.05.040", "26051832"]}, {"Citation": "Danciu C, Muntean D, Alexa E, Farcas C, Oprean C, Zupko I, et al. . Phytochemical characterization and evaluation of the antimicrobial, antiproliferative and pro-apoptotic potential of Ephedra alata Decne. hydroalcoholic extract against the MCF-7 breast cancer cell line. Molecules. (2018) 24:13. 10.3390/molecules24010013", "ArticleIdList": ["10.3390/molecules24010013", "PMC6337526", "30577537"]}, {"Citation": "Churqui MP, Lind L, Th\u00f6rn K, Svensson A, Savolainen O, Aranda KT, et al. . Extracts of Equisetum giganteum L and Copaifera reticulate Ducke show strong antiviral activity against the sexually transmitted pathogen herpes simplex virus type 2. J Ethnopharmacol. (2018) 210:192\u20137. 10.1016/j.jep.2017.08.010", "ArticleIdList": ["10.1016/j.jep.2017.08.010", "28807852"]}, {"Citation": "Shamsabadipour S, Ghanadian M, Saeedi H, Reza Rahimnejad M, Mohammadi-Kamalabadi M, Ayatollahi SM, et al. . Triterpenes and steroids from Euphorbia denticulata Lam. with anti-herpes symplex virus activity. Iran J Pharm Res. (2013) 12:759\u201367.", "ArticleIdList": ["PMC3920720", "24523756"]}, {"Citation": "Gyuris A, Szl\u00e1vik L, Min\u00e1rovits J, Vasas A, Moln\u00e1r J, Hohmann J. Antiviral activities of extracts of Euphorbia hirta L. against HIV-1, HIV-2 and SIVmac251. In Vivo. (2008) 23:429\u201332.", "ArticleIdList": ["19454510"]}, {"Citation": "Jiang C, Luo P, Zhao Y, Hong J, Morris-Natschke SL, Xu J, et al. . Carolignans from the aerial parts of Euphorbia sikkimensis and their anti-HIV activity. J Nat Prod. (2016) 79:578\u201383. 10.1021/acs.jnatprod.5b01012", "ArticleIdList": ["10.1021/acs.jnatprod.5b01012", "PMC4808429", "26756779"]}, {"Citation": "Shoji M, Woo SY, Masuda A, Win NN, Ngwe H, Takahashi E, et al. . Anti-influenza virus activity of extracts from the stems of Jatropha multifida Linn. Collected in Myanmar. BMC Complement Altern Med. (2017) 17:76. 10.1186/s12906-017-1612-8", "ArticleIdList": ["10.1186/s12906-017-1612-8", "PMC5297253", "28173854"]}, {"Citation": "Ghoke SS, Sood R, Kumar N, Pateriya AK, Bhatia S, Mishra A, et al. . Evaluation of antiviral activity of Ocimum sanctum and Acacia arabica leaves extracts against H9N2 virus using embryonated chicken egg model. BMC Complement Altern Med. (2018) 18:174. 10.1186/s12906-018-2238-1", "ArticleIdList": ["10.1186/s12906-018-2238-1", "PMC5987647", "29866088"]}, {"Citation": "Makau JN, Watanabe K, Mohammed MMD, Nishida N. Antiviral activity of peanut (Arachis hypogaea L.) skin extract against human influenza viruses. J Med Food. (2018) 21:777\u201384. 10.1089/jmf.2017.4121", "ArticleIdList": ["10.1089/jmf.2017.4121", "29847745"]}, {"Citation": "Knipping K, Garssen J, van't Land B. An evaluation of the inhibitory effects against rotavirus infection of edible plant extracts. Virol J. (2012) 9:137. 10.1186/1743-422X-9-137", "ArticleIdList": ["10.1186/1743-422X-9-137", "PMC3439294", "22834653"]}, {"Citation": "Fahmy NM, Al-Sayed E, Moghannem S, Azam F, El-Shazly M, Singab AN. Breaking down the barriers to a natural antiviral agent: antiviral activity and molecular docking of Erythrina speciosa extract, fractions, and the major compound. Chem Biodivers. (2020) 17:2. 10.1002/cbdv.201900511", "ArticleIdList": ["10.1002/cbdv.201900511", "31800173"]}, {"Citation": "Donalisio M, Cagno V, Civra A, Gibellini D, Musumeci G, Ritt\u00e0 M, et al. . The traditional use of Vachellia nilotica for sexually transmitted diseases is substantiated by the antiviral activity of its bark extract against sexually transmitted viruses. J Ethnopharmacol. (2018) 213:403\u20138. 10.1016/j.jep.2017.11.039", "ArticleIdList": ["10.1016/j.jep.2017.11.039", "29203273"]}, {"Citation": "Nutan SK, Modi M, Dezzutti CS, Kulshreshtha S, Rawat AKS, Srivastava SK, et al. . Extracts from Acacia catechu suppress HIV-1 replication by inhibiting the activities of the viral protease and Tat. Virol J. (2013) 10:309. 10.1186/1743-422X-10-309", "ArticleIdList": ["10.1186/1743-422X-10-309", "PMC3819669", "25228267"]}, {"Citation": "Karimi A, Rafieian-kopaei M, Moradi M. Anti -herpes simplex virus type-1 activity and phenolic content of crude ethanol extract and four corresponding fractions of Quercus brantii L Acorn. J Evid Based Complement Altern Med. (2016) 22:455\u201361. 10.1177/2156587216676421", "ArticleIdList": ["10.1177/2156587216676421", "PMC5871161", "27899436"]}, {"Citation": "Rafieian-kopaei M, Saeedi M, Asgari S, Karimi A, Moradi M-T. Antiviral activity of Quercus persica L.: high efficacy and low toxicity. Adv Biomed Res. (2013) 2:36. 10.4103/2277-9175.109722", "ArticleIdList": ["10.4103/2277-9175.109722", "PMC3905353", "24516836"]}, {"Citation": "Choi JG, Kim YS, Kim JH, Chung HS. Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition. Sci Rep. (2019) 9:12132. 10.1038/s41598-019-48430-8", "ArticleIdList": ["10.1038/s41598-019-48430-8", "PMC6702199", "31431635"]}, {"Citation": "Helfer M, Koppensteiner H, Schneider M, Rebensburg S, Forcisi S, M\u00fcller C, et al. . The root extract of the medicinal plant Pelargonium sidoides is a potent HIV-1 attachment inhibitor. PLoS ONE. (2014) 9:e87487. 10.1371/journal.pone.0087487", "ArticleIdList": ["10.1371/journal.pone.0087487", "PMC3906173", "24489923"]}, {"Citation": "Michaelis M, Doerr HW, Cinatl J. Investigation of the influence of EPs\u00ae 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine. (2011) 18:384\u20136. 10.1016/j.phymed.2010.09.008", "ArticleIdList": ["10.1016/j.phymed.2010.09.008", "PMC7127141", "21036571"]}, {"Citation": "Haasbach E, Hartmayer C, Hettler A, Sarnecka A, Wulle U, Ehrhardt C, et al. . Antiviral activity of Ladania067, an extract from wild black currant leaves against influenza a virus in vitro and in vivo. Front Microbiol. (2014) 5:171. 10.3389/fmicb.2014.00171", "ArticleIdList": ["10.3389/fmicb.2014.00171", "PMC4001074", "24795704"]}, {"Citation": "Theisen LL, Erdelmeier CAJ, Spoden GA, Boukhallouk F, Sausy A, Florin L, et al. . Tannins from Hamamelis virginiana bark extract: characterization and improvement of the antiviral efficacy against influenza, a virus and human papillomavirus. PLoS ONE. (2014) 9:e88062. 10.1371/journal.pone.0088062", "ArticleIdList": ["10.1371/journal.pone.0088062", "PMC3909258", "24498245"]}, {"Citation": "Erdelmeier CAJ, Cinatl J, Rabenau H, Doerr HW, Biber A, Koch E. Antiviral and antiphlogistic activities of Hamamelis virginiana bark. Planta Med. (1996) 62:241\u20135. 10.1055/s-2006-957868", "ArticleIdList": ["10.1055/s-2006-957868", "8693037"]}, {"Citation": "Chen SG, Leu YL, Cheng ML, Ting SC, Liu CC, Wang S Der, et al. . Anti-enterovirus 71 activities of Melissa officinalis extract and its biologically active constituent rosmarinic acid. Sci Rep. (2017) 7:12264. 10.1038/s41598-017-12388-2", "ArticleIdList": ["10.1038/s41598-017-12388-2", "PMC5613005", "28947773"]}, {"Citation": "Schnitzler P, Schuhmacher A, Astani A, Reichling J. Melissa officinalis oil affects infectivity of enveloped herpesviruses. Phytomedicine. (2008) 15:734\u201340. 10.1016/j.phymed.2008.04.018", "ArticleIdList": ["10.1016/j.phymed.2008.04.018", "18693101"]}, {"Citation": "Tang LIC, Ling APK, Koh RY, Chye SM, Voon KGL. Screening of anti-dengue activity in methanolic extracts of medicinal plants. BMC Complement Altern Med. (2012) 12:3. 10.1186/1472-6882-12-3", "ArticleIdList": ["10.1186/1472-6882-12-3", "PMC3269354", "22244370"]}, {"Citation": "Chiu LCM, Zhu W, Ooi VEC. A polysaccharide fraction from medicinal herb Prunella vulgaris downregulates the expression of herpes simplex virus antigen in Vero cells. J Ethnopharmacol. (2004) 93:63\u20138. 10.1016/j.jep.2004.03.024", "ArticleIdList": ["10.1016/j.jep.2004.03.024", "15182906"]}, {"Citation": "Brindley MA, Widrlechner MP, McCoy JA, Murphy P, Hauck C, Rizshsky L, et al. . Inhibition of lentivirus replication by aqueous extracts of Prunella vulgaris. Virol J. (2009) 6:8. 10.1186/1743-422X-6-8", "ArticleIdList": ["10.1186/1743-422X-6-8", "PMC2645367", "19154592"]}, {"Citation": "Ma F-W, Kong S-Y, Tan H-S, Wu R, Xia B, Zhou Y, et al. . Structural characterization and antiviral effect of a novel polysaccharide PSP-2B from Prunellae Spica. Carbohydr Polym. (2016) 152:699\u2013709. 10.1016/j.carbpol.2016.07.062", "ArticleIdList": ["10.1016/j.carbpol.2016.07.062", "27516321"]}, {"Citation": "Mancini DAP, Torres RP, Pinto JR, Mancini-Filho J. Inhibition of DNA virus: Herpes-1 (HSV-1) in cellular culture replication, through an antioxidant treatment extracted from rosemary spice. Brazilian J Pharm Sci. (2009) 45:127\u201333. 10.1590/S1984-82502009000100016", "ArticleIdList": ["10.1590/S1984-82502009000100016"]}, {"Citation": "Shi H, Ren K, Lv B, Zhang W, Zhao Y, Tan RX, et al. . Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice. Sci Rep. (2016) 6:35851. 10.1038/srep35851", "ArticleIdList": ["10.1038/srep35851", "PMC5073294", "27767097"]}, {"Citation": "Cao YG, Hao Y, Li ZH, Liu ST, Wang LX. Antiviral activity of polysaccharide extract from Laminaria japonica against respiratory syncytial virus. Biomed Pharmacother. (2016) 84:1705\u201310. 10.1016/j.biopha.2016.10.082", "ArticleIdList": ["10.1016/j.biopha.2016.10.082", "27847204"]}, {"Citation": "Yarmolinsky L, Zaccai M, Ben-shabat S, Mills D, Huleihel M. Antiviral activity of ethanol extracts of Ficus binjamina and Lilium candidum in vitro. (2009) 26:307\u201313. 10.1016/j.nbt.2009.08.005", "ArticleIdList": ["10.1016/j.nbt.2009.08.005", "19703599"]}, {"Citation": "Tsai YC, Hohmann J, El-Shazly M, Chang LK, Dank\u00f3 B, K\u00fasz N, et al. . Bioactive constituents of Lindernia crustacea and its anti-EBV effect via Rta expression inhibition in the viral lytic cycle. J Ethnopharmacol. (2020) 250:112493. 10.1016/j.jep.2019.112493", "ArticleIdList": ["10.1016/j.jep.2019.112493", "31863859"]}, {"Citation": "Boff L, Silva IT, Argenta DF, Farias LM, Alvarenga LF, P\u00e1dua RM. Strychnos pseudoquina A. St. Hil.: a Brazilian medicinal plant with promising in vitro antiherpes activity. J Appl Microbiol. (2016) 121:1519\u201329. 10.1111/jam.13279", "ArticleIdList": ["10.1111/jam.13279", "27566664"]}, {"Citation": "Arunkumar J, Rajarajan S. Study on antiviral activities, drug-likeness and molecular docking of bioactive compounds of Punica granatum L. to Herpes simplex virus - 2 (HSV-2). Microb Pathog. (2018) 118:301\u20139. 10.1016/j.micpath.2018.03.052", "ArticleIdList": ["10.1016/j.micpath.2018.03.052", "29604421"]}, {"Citation": "Haidari M, Ali M, Ward Casscells S, Madjid M. Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir. Phytomedicine. (2009) 16:1127\u201336. 10.1016/j.phymed.2009.06.002", "ArticleIdList": ["10.1016/j.phymed.2009.06.002", "19586764"]}, {"Citation": "Fang C, Chen S, Wu H, Ping Y, Lin C. Honokiol, a Lignan biphenol derived from the magnolia tree, inhibits Dengue virus type 2 infection. Viruses. (2015) 7:4894\u2013910. 10.3390/v7092852", "ArticleIdList": ["10.3390/v7092852", "PMC4584296", "26378567"]}, {"Citation": "Baatartsogt T, Bui VN, Trinh DQ, Yamaguchi E, Gronsang D, Thampaisarn R, et al. . High antiviral effects of hibiscus tea extract on the H5 subtypes of low and highly pathogenic avian influenza viruses. J Vet Med Sci. (2016) 78:1405\u201311. 10.1292/jvms.16-0124", "ArticleIdList": ["10.1292/jvms.16-0124", "PMC5059367", "27193820"]}, {"Citation": "Sood R, Raut R, Tyagi P, Pareek PK, Barman TK, Singhal S, et al. . Cissampelos pareira Linn: Natural source of potent antiviral activity against all four Dengue virus serotypes. PLoS Negl Trop Dis. (2015) 9:e0004255. 10.1371/journal.pntd.0004255", "ArticleIdList": ["10.1371/journal.pntd.0004255", "PMC4692392", "26709822"]}, {"Citation": "Yarmolinsky L, Huleihel M, Zaccai M, Ben-shabat S. Potent antiviral flavone glycosides from Ficus benjamina leaves. Fitoterapia. (2012) 83:362\u20137. 10.1016/j.fitote.2011.11.014", "ArticleIdList": ["10.1016/j.fitote.2011.11.014", "22155188"]}, {"Citation": "Aref HL, Gaaliche B, Fekih A. in vitro cytotoxic and antiviral activities of Ficus carica latex extracts. Nat Prod Res. (2011) 25:310\u20139. 10.1080/14786419.2010.528758", "ArticleIdList": ["10.1080/14786419.2010.528758", "21294043"]}, {"Citation": "Ghosh M, Civra A, Ritt\u00e0 M, Cagno V, Mavuduru SG, Awasthi P, et al. . Ficus religiosa L. bark extracts inhibit infection by herpes simplex virus type 2 in vitro. Arch Virol. (2016) 161:3509\u201314. 10.1007/s00705-016-3032-3", "ArticleIdList": ["10.1007/s00705-016-3032-3", "27581805"]}, {"Citation": "Huang NC, Hung WT, Tsai WL, Lai FY, Lin YS, Huang MS, et al. . Ficus septica plant extracts for treating Dengue virus in vitro. Peer J. (2017) 5:e3448. 10.7717/peerj.3448", "ArticleIdList": ["10.7717/peerj.3448", "PMC5466810", "28607841"]}, {"Citation": "Sa S, Abdullahi H. Antifungal activity and phytochemical analysis of Ficus sycomorus leaf extract on malassezia glubosa. Adv Plants Agric Res. (2018) 8:432\u20136. 10.15406/apar.2018.08.00362", "ArticleIdList": ["10.15406/apar.2018.08.00362"]}, {"Citation": "Batiha GES, Alkazmi LM, Wasef LG, Beshbishy AM, Nadwa EH, Rashwan EK. Syzygium aromaticum L. (myrtaceae): traditional uses, bioactive chemical constituents, pharmacological and toxicological activities. Biomolecules. (2020) 10:202. 10.3390/biom10020202", "ArticleIdList": ["10.3390/biom10020202", "PMC7072209", "32019140"]}, {"Citation": "Benzekri R, Bouslama L, Papetti A, Hammami M, Smaoui A, Limam F. Anti HSV-2 activity of Peganum harmala (L.) and isolation of the active compound. Microb Pathog. (2018) 114:291\u20138. 10.1016/j.micpath.2017.12.017", "ArticleIdList": ["10.1016/j.micpath.2017.12.017", "29223449"]}, {"Citation": "Li J, Yang X, Huang L. Anti-Influenza virus activity and constituents characterization of Paeonia delavayi extracts. Molecules. (2016) 21:1133. 10.3390/molecules21091133", "ArticleIdList": ["10.3390/molecules21091133", "PMC6273231", "27571059"]}, {"Citation": "Ho JY, Chang HW, Lin CF, Liu CJ, Hsieh CF, Horng JT. Characterization of the anti-influenza activity of the Chinese herbal plant Paeonia lactiflora. Viruses. (2014) 6:1861\u201375. 10.3390/v6041861", "ArticleIdList": ["10.3390/v6041861", "PMC4014724", "24762393"]}, {"Citation": "Cho JK, Curtis-Long MJ, Lee KH, Kim DW, Ryu HW, Yuk HJ, et al. . Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa. Bioorganic Med Chem. (2013) 21:3051\u20137. 10.1016/j.bmc.2013.03.027", "ArticleIdList": ["10.1016/j.bmc.2013.03.027", "PMC7126831", "23623680"]}, {"Citation": "Lv J, Yu S, Wang Y, Wang D, Zhu H, Cheng R, et al. . Anti-hepatitis B virus norbisabolane sesquiterpenoids from Phyllanthus acidus and the establishment of their absolute configurations using theoretical calculations. J Org Chem. (2014) 79:5432\u201347. 10.1021/jo5004604", "ArticleIdList": ["10.1021/jo5004604", "24824117"]}, {"Citation": "Ravikumar YS, Ray U, Nandhitha M, Perween A, Raja Naika H, Khanna N, et al. . Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source. Virus Res. (2011) 158:89\u201397. 10.1016/j.virusres.2011.03.014", "ArticleIdList": ["10.1016/j.virusres.2011.03.014", "21440018"]}, {"Citation": "Tan WC, Jaganath IB, Manikam R, Sekaran SD. Evaluation of antiviral activities of four local Malaysian phyllanthus species against herpes simplex viruses and possible antiviral target. Int J Med Sci. (2013) 10:1817\u201329. 10.7150/ijms.6902", "ArticleIdList": ["10.7150/ijms.6902", "PMC3856372", "24324358"]}, {"Citation": "Zhang X, Yang LM, Liu GM, Liu YJ, Zheng CB, Lv YJ, et al. . Potent anti-HIV activities and mechanisms of action of a pine cone extract from Pinus yunnanensis. Molecules. (2012) 17:6916\u201329. 10.3390/molecules17066916", "ArticleIdList": ["10.3390/molecules17066916", "PMC6268540", "22728366"]}, {"Citation": "Hsu WC, Chang SP, Lin LC, Li CL, Richardson CD, Lin CC, et al. . Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry. Antiviral Res. (2015) 118:139\u201347. 10.1016/j.antiviral.2015.04.003", "ArticleIdList": ["10.1016/j.antiviral.2015.04.003", "25865056"]}, {"Citation": "Chavan RD, Shinde P, Girkar K, Madage R, Chowdhary A. Assessment of Anti-Influenza activity and hemagglutination inhibition of Plumbago indica and Allium sativum extracts. Pharmacognosy Res. (2016) 8:105\u201311. 10.4103/0974-8490.172562", "ArticleIdList": ["10.4103/0974-8490.172562", "PMC4780135", "27034600"]}, {"Citation": "Xiong HR, Luo J, Hou W, Xiao H, Yang ZQ. The effect of Emodin, an anthraquinone derivative extracted from the roots of Rheum tanguticum, against herpes simplex virus in vitro and in vivo. J Ethnopharmacol. (2011) 133:718\u201323. 10.1016/j.jep.2010.10.059", "ArticleIdList": ["10.1016/j.jep.2010.10.059", "PMC7126445", "21050882"]}, {"Citation": "Su M, Li Y, Leung KT, Cen Y, Li T, Chen R, et al. . Antiviral activity and constituent of Ardisia Chinensis Benth against coxsackie B3 virus. Phytother Res. (2006) 20:634\u20139. 10.1002/ptr.1912", "ArticleIdList": ["10.1002/ptr.1912", "16775812"]}, {"Citation": "Hossan MS, Fatima A, Rahmatullah M, Khoo TJ, Nissapatorn V, Galochkina AV, et al. . Antiviral activity of Embelia ribes Burm. f. against influenza virus in vitro. Arch Virol. (2018) 163:2121\u201331. 10.1007/s00705-018-3842-6", "ArticleIdList": ["10.1007/s00705-018-3842-6", "29633078"]}, {"Citation": "Hung TC, Jassey A, Lin CJ, Liu CH, Lin CC, Yen MH, et al. . Methanolic extract of rhizoma coptidis inhibits the early viral entry steps of hepatitis C virus infection. Viruses. (2018) 10:669. 10.3390/v10120669", "ArticleIdList": ["10.3390/v10120669", "PMC6315547", "30486350"]}, {"Citation": "Kim HB, Lee CY, Kim SJ, Han JH, Choi KH. Medicinal herb extracts ameliorate impaired growth performance and intestinal lesion of newborn piglets challenged with the virulent porcine epidemic diarrhea virus. J Anim Sci Technol. (2015) 57:33. 10.1186/s40781-015-0065-1", "ArticleIdList": ["10.1186/s40781-015-0065-1", "PMC4597758", "26451253"]}, {"Citation": "Shin WJ, Lee KH, Park MH, Seong BL. Broad-spectrum antiviral effect of Agrimonia pilosa extract on influenza viruses. Microbiol Immunol. (2010) 54:11\u20139. 10.1111/j.1348-0421.2009.00173.x", "ArticleIdList": ["10.1111/j.1348-0421.2009.00173.x", "20055938"]}, {"Citation": "Bisignano C, Mandalari G, Smeriglio A, Trombetta D, Pizzo MM, Pennisi R, et al. . Almond skin extracts abrogate HSV-1 replication by blocking virus binding to the cell. Viruses. (2017) 9:178. 10.3390/v9070178", "ArticleIdList": ["10.3390/v9070178", "PMC5537670", "28698509"]}, {"Citation": "Ratnoglik SL, Aoki C, Sudarmono P, Komoto M, Deng L, Shoji I, et al. . Antiviral activity of extracts from Morinda citrifolia leaves and chlorophyll catabolites, pheophorbide a and pyropheophorbide a, against hepatitis C virus. Microbiol Immunol. (2014) 58:188\u201394. 10.1111/1348-0421.12133", "ArticleIdList": ["10.1111/1348-0421.12133", "24438164"]}, {"Citation": "Pratheeba T, Taranath V, Sai Gopal DVR, Natarajan D. Antidengue potential of leaf extracts of Pavetta tomentosa and Tarenna asiatica (Rubiaceae) against dengue virus and its vector Aedes aegypti (Diptera: Culicidae). Heliyon. (2019) 5:e02732. 10.1016/j.heliyon.2019.e02732", "ArticleIdList": ["10.1016/j.heliyon.2019.e02732", "PMC6889234", "31844692"]}, {"Citation": "Brijesh S, Daswani P, Tetali P, Antia N, Birdi T. Studies on the antidiarrhoeal activity of Aegle marmelos unripe fruit : validating its traditional usage. BMC Complement Altern Med. (2009) 12:47. 10.1186/1472-6882-9-47", "ArticleIdList": ["10.1186/1472-6882-9-47", "PMC2788518", "19930633"]}, {"Citation": "Apriyanto DR, Aoki C, Hartati S, Hanafi M, Kardono LBS, Arsianti A, et al. . Anti-hepatitis C virus activity of a crude extract from longan (Dimocarpus longan Lour.) leaves. Jpn J Infect Dis. (2016) 69:213\u201320. 10.7883/yoken.JJID.2015.107", "ArticleIdList": ["10.7883/yoken.JJID.2015.107", "26255732"]}, {"Citation": "Song JH, Ahn JH, Kim SR, Cho S, Hong EH, Kwon BE, et al. . Manassantin B shows antiviral activity against coxsackievirus B3 infection by activation of the STING/TBK-1/IRF3 signalling pathway. Sci Rep. (2019) 9:9413. 10.1038/s41598-019-45868-8", "ArticleIdList": ["10.1038/s41598-019-45868-8", "PMC6599049", "31253850"]}, {"Citation": "Wang GW, Hu WT, Huang BK, Qin LP. Illicium verum: a review on its botany, traditional use, chemistry and pharmacology. J Ethnopharmacol. (2011) 136:10\u201320. 10.1016/j.jep.2011.04.051", "ArticleIdList": ["10.1016/j.jep.2011.04.051", "21549817"]}, {"Citation": "Abdelgawad AAM. Tamarix nilotica (Ehrenb) bunge: a review of phytochemistry and pharmacology. J Microb Biochem Technol. (2017) 9:544\u201353. 10.4172/1948-5948.1000340", "ArticleIdList": ["10.4172/1948-5948.1000340"]}, {"Citation": "Ryu YB, Jeong HJ, Kim JH, Kim YM, Park JY, Kim D, et al. . Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition. Bioorganic Med Chem. (2010) 18:7940\u20137. 10.1016/j.bmc.2010.09.035", "ArticleIdList": ["10.1016/j.bmc.2010.09.035", "PMC7126309", "20934345"]}, {"Citation": "Karamese M, Aydogdu S, Karamese SA, Altoparlak U. Preventive effects of a major component of green tea, Epigallocathechin-3-Gallate, on Hepatitis-B virus DNA replication. Asian Pac J Cancer Prev. (2015) 16:40199\u2013202. 10.7314/APJCP.2015.16.10.4199", "ArticleIdList": ["10.7314/APJCP.2015.16.10.4199", "26028072"]}, {"Citation": "Xu J, Wang J, Deng F, Hu Z, Wang H. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro. Antiviral Res. (2008) 78:242\u20139. 10.1016/j.antiviral.2007.11.011", "ArticleIdList": ["10.1016/j.antiviral.2007.11.011", "18313149"]}, {"Citation": "Dai J, Tao H, Min Q, Zhu Q. Anti-hepatitis B virus activities of friedelolactones from Viola diffusa Ging. Phytomedicine. (2015) 22:724\u20139. 10.1016/j.phymed.2015.05.001", "ArticleIdList": ["10.1016/j.phymed.2015.05.001", "26141758"]}, {"Citation": "Kwon HJ, Kim HH, Yoon SY, Ryu YB, Chang JS, Cho KO, et al. . in vitro inhibitory activity of Alpinia katsumadai extracts against influenza virus infection and hemagglutination. Virol J. (2010) 7:307. 10.1186/1743-422X-7-307", "ArticleIdList": ["10.1186/1743-422X-7-307", "PMC2989970", "21062499"]}, {"Citation": "Thuy BTP, My TTA, Hai NTT, Hieu LT, Hoa TT, Thi Phuong Loan H, et al. Investigation into SARS-CoV-2 resistance of compounds in garlic essential oil. ACS Omega. (2020) 5:8312\u20138320. 10.1021/acsomega.0c00772", "ArticleIdList": ["10.1021/acsomega.0c00772", "PMC7123907", "32363255"]}, {"Citation": "Kim DW, Seo KH, Curtis-Long MJ, Oh KY, Oh JW, Cho JK, et al. . Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. J Enzyme Inhib Med Chem. (2014) 29:59\u201363. 10.3109/14756366.2012.753591", "ArticleIdList": ["10.3109/14756366.2012.753591", "23323951"]}, {"Citation": "Li SY, Chen C, Zhang HQ, Guo HY, Wang H, Wang L, et al. . Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. (2005) 67:18\u201323. 10.1016/j.antiviral.2005.02.007", "ArticleIdList": ["10.1016/j.antiviral.2005.02.007", "PMC7114104", "15885816"]}, {"Citation": "Ulasli M, Gurses SA, Bayraktar R, Yumrutas O, Oztuzcu S, Igci M, et al. . The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family. Mol Biol Rep. (2014) 41:1703\u201311. 10.1007/s11033-014-3019-7", "ArticleIdList": ["10.1007/s11033-014-3019-7", "PMC3933739", "24413991"]}, {"Citation": "Ryu YB, Park SJ, Kim YM, Lee JY, Seo WD, Chang JS, et al. . SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii. Bioorganic Med Chem Lett. (2010) 20:1873\u201376. 10.1016/j.bmcl.2010.01.152", "ArticleIdList": ["10.1016/j.bmcl.2010.01.152", "PMC7127101", "20167482"]}, {"Citation": "Loizzo MR, Saab AM, Tundis R, Statti GA, Menichimi F, Lampronti D, et al. . Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species. Chem Biodivers. (2008) 5:461\u201370. 10.1002/cbdv.200890045", "ArticleIdList": ["10.1002/cbdv.200890045", "PMC7161995", "18357554"]}, {"Citation": "Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, et al. . Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B. (2020) 10:766\u201388. 10.1016/j.apsb.2020.02.008", "ArticleIdList": ["10.1016/j.apsb.2020.02.008", "PMC7102550", "32292689"]}, {"Citation": "Wen CC, Shyur LF, Jan JT, Liang PH, Kuo CJ, Arulselvan P, et al. . Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication. J Tradit Complement Med. (2011) 1:41\u201350. 10.1016/S2225-4110(16)30055-4", "ArticleIdList": ["10.1016/S2225-4110(16)30055-4", "PMC3942999", "24716104"]}, {"Citation": "Zhuang M, Jiang H, Suzuki Y, Li X, Xiao P, Tanaka T, et al. . Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection. Antiviral Res. (2009) 82:73\u201381. 10.1016/j.antiviral.2009.02.001", "ArticleIdList": ["10.1016/j.antiviral.2009.02.001", "PMC7114128", "19428598"]}, {"Citation": "Ho TY, Wu SL, Chen JC, Li CC, Hsiang CY. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. (2007) 74:92\u2013101. 10.1016/j.antiviral.2006.04.014", "ArticleIdList": ["10.1016/j.antiviral.2006.04.014", "PMC7114332", "16730806"]}, {"Citation": "Luo W, Su X, Gong S, Qin Y, Liu W, Li J, et al. . Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. Biosci Trends. (2009) 3:124\u20136.", "ArticleIdList": ["20103835"]}, {"Citation": "Yang C, Lee Y, Hsu H, Shih C, Chao Y, Lee S. Targeting coronaviral replication and cellular JAK2 mediated dominant NF- \u03baB activation for comprehensive and ultimate inhibition of coronaviral activity. Sci Rep. (2017) 7:4105. 10.1038/s41598-017-04203-9", "ArticleIdList": ["10.1038/s41598-017-04203-9", "PMC5481340", "28642467"]}, {"Citation": "Adhikari SP, Meng S, Wu Y, Mao Y, Ye R, Wang Q, et al. . Novel Coronavirus during the early outbreak period: epidemiology, causes, clinical manifestation and diagnosis, prevention and control. Infect Dis Poverty. (2020) 9:29. 10.1186/s40249-020-00646-x", "ArticleIdList": ["10.1186/s40249-020-00646-x", "PMC7079521", "32183901"]}, {"Citation": "Nickbakhsh S, Ho A, Marques DFP, McMenamin J, Gunson RN, Murcia PR. Epidemiology of seasonal coronaviruses: establishing the context for the emergence of Coronavirus disease 2019. J Infect Dis. (2020) 222:17\u201325. 10.1093/infdis/jiaa185", "ArticleIdList": ["10.1093/infdis/jiaa185", "PMC7184404", "32296837"]}, {"Citation": "Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: what we know. Int J Infect Dis. (2020) 94:44\u20138. 10.1016/j.ijid.2020.03.004", "ArticleIdList": ["10.1016/j.ijid.2020.03.004", "PMC7102543", "32171952"]}, {"Citation": "Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. . Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. (2020) 382:1199\u2013207. 10.1056/NEJMoa2001316", "ArticleIdList": ["10.1056/NEJMoa2001316", "PMC7121484", "31995857"]}, {"Citation": "Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen TV, Nguyen HT, et al. . Importation and human-to-human transmission of a novel Coronavirus in Vietnam. N Engl J Med. (2020) 382:872\u20134. 10.1056/NEJMc2001272", "ArticleIdList": ["10.1056/NEJMc2001272", "PMC7121428", "31991079"]}, {"Citation": "Cots JM, Al\u00f3s J, B\u00e1rcena M, Boleda X. COVID-19 in Brazil: \u201cSo what?\u201d. Lancet. (2020) 395:1461. 10.1016/S0140-6736(20)31095-3", "ArticleIdList": ["10.1016/S0140-6736(20)31095-3", "PMC7251993", "32386576"]}, {"Citation": "COVID-19 Dashboard by the Center for Systems Science Engineering (CSSE) at Johns Hopkins University (JHU). Available online at: https://coronavirus.jhu.edu/map.html (accessed July 5, 2020)."}, {"Citation": "Yang H, Bartlam M, Rao Z. Drug design targeting the main protease, the Achilles Heel of coronaviruses. Curr Pharm Des. (2006) 12:4573\u201390. 10.2174/138161206779010369", "ArticleIdList": ["10.2174/138161206779010369", "17168763"]}, {"Citation": "Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect. (2020). 10.1016/j.jmii.2020.03.022. [Epub ahead of print].", "ArticleIdList": ["10.1016/j.jmii.2020.03.022.", "PMC7138183", "32265180"]}, {"Citation": "Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. . Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. (2020) 11:1620. 10.1038/s41467-020-15562-9", "ArticleIdList": ["10.1038/s41467-020-15562-9", "PMC7100515", "32221306"]}, {"Citation": "Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. (2020) 176:140742. 10.1016/j.antiviral.2020.104742", "ArticleIdList": ["10.1016/j.antiviral.2020.104742", "PMC7114094", "32057769"]}, {"Citation": "Liang Y, Wang M, Chien C, Yarmishyn AA. Highlight of immune pathogenic response and hematopathologic effect in SARS-CoV, MERS-CoV and SARS-Cov-2 infection. Front Immunol. (2020) 11:1022. 10.3389/fimmu.2020.01022", "ArticleIdList": ["10.3389/fimmu.2020.01022", "PMC7236801", "32574260"]}, {"Citation": "Chen B, Tian E, He B, Tian L, Han R, Wang S, et al. . Overview of lethal human coronaviruses. Sig Transduct Target Ther. (2020) 5:89. 10.1038/s41392-020-0190-2", "ArticleIdList": ["10.1038/s41392-020-0190-2", "PMC7289715", "32533062"]}, {"Citation": "Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov. (2020) 6:14. 10.1038/s41421-020-0153-3", "ArticleIdList": ["10.1038/s41421-020-0153-3", "PMC7073332", "32194980"]}, {"Citation": "Xu J, Zhao S, Teng T, Abdalla AE, Zhu W, Xie L, et al. . Systematic comparison of two animal-to-human transmitted human Coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses. (2020) 12:244. 10.3390/v12020244", "ArticleIdList": ["10.3390/v12020244", "PMC7077191", "32098422"]}, {"Citation": "Prajapat M, Sarma P, Shekhar N, Avti P, Sinha S, Kaur H, et al. . Drug targets for corona virus: a systematic review. Indian J Pharmacol. (2020) 52:56\u201365. 10.4103/ijp.IJP_115_20", "ArticleIdList": ["10.4103/ijp.IJP_115_20", "PMC7074424", "32201449"]}, {"Citation": "Rabaan AA, Al-Ahmed SH, Haque S, Sah R, Tiwari R, Malik YS, et al. . SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Le Infez Med. (2020) 28:174\u201384.", "ArticleIdList": ["32275259"]}, {"Citation": "Tang X, Wu C, Li X, Song Y, Yao X, Wu X, et al. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev. (2020) 3:nwaa036 10.1093/nsr/nwaa036", "ArticleIdList": ["10.1093/nsr/nwaa036", "PMC7107875", "34676127"]}, {"Citation": "Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. (2020) 46:586\u201390. 10.1007/s00134-020-05985-9", "ArticleIdList": ["10.1007/s00134-020-05985-9", "PMC7079879", "32125455"]}, {"Citation": "Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020) 2:52 10.1016/j.cell.2020.02.052", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Skariayachan S, Challapilli SB, Pacckirisamy S, Kumargowda ST, Sridhar VS. Recent aspects on the pathogenesis mechanism, animal models and novel therapeutics interventions for Middle East respiratory syndrome coronavirus infections. Front Microbiol. (2019) 10:569. 10.3389/fmicb.2019.00569", "ArticleIdList": ["10.3389/fmicb.2019.00569", "PMC6448012", "30984127"]}, {"Citation": "Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res. (2020) 24:91\u20138. 10.1016/j.jare.2020.03.005", "ArticleIdList": ["10.1016/j.jare.2020.03.005", "PMC7113610", "32257431"]}, {"Citation": "Rampersad S, Tennant P. Replication and expression strategies of viruses. Viruses. (2018) 2018:55\u201382. 10.1016/B978-0-12-811257-1.00003-6", "ArticleIdList": ["10.1016/B978-0-12-811257-1.00003-6"]}, {"Citation": "Wang H, Xue S, Yang H, Chen C. Recent progress in the discovery of inhibitors targeting coronavirus proteases. Virol Sin. (2016) 31:24\u201330. 10.1007/s12250-015-3711-3", "ArticleIdList": ["10.1007/s12250-015-3711-3", "PMC7090653", "26920707"]}, {"Citation": "Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res. (2020) 30:367\u20139. 10.1038/s41422-020-0327-4", "ArticleIdList": ["10.1038/s41422-020-0327-4", "PMC7186532", "32346073"]}, {"Citation": "Rockx B, Kuiken T, Herfst S, Bestebroer T, Lamers MM, Oude Munnink BB, et al. . Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science. (2020) 368:1012\u20135. 10.1126/science.abb7314", "ArticleIdList": ["10.1126/science.abb7314", "PMC7164679", "32303590"]}, {"Citation": "Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. (2020) 92:418\u201323. 10.1002/jmv.25681", "ArticleIdList": ["10.1002/jmv.25681", "PMC7167049", "31967327"]}, {"Citation": "Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H. The architecture of SARS-CoV-2 transcriptome. Cell. (2020) 181:914\u201321. 10.1016/j.cell.2020.04.011", "ArticleIdList": ["10.1016/j.cell.2020.04.011", "PMC7179501", "32330414"]}, {"Citation": "Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, et al. . COVID-19 infection: the perspectives on immune responses. Cell Death Differ. (2020) 27:1451\u20134. 10.1038/s41418-020-0530-3", "ArticleIdList": ["10.1038/s41418-020-0530-3", "PMC7091918", "32205856"]}, {"Citation": "Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. (2020) 395:497\u2013506. 10.1016/S0140-6736(20)30183-5", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. (2020) 109:102433. 10.1016/j.jaut.2020.102433", "ArticleIdList": ["10.1016/j.jaut.2020.102433", "PMC7127067", "32113704"]}, {"Citation": "Devaux CA, Rolain JM, Raoult D. ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect. (2020) 53:425\u201335. 10.1016/j.jmii.2020.04.015", "ArticleIdList": ["10.1016/j.jmii.2020.04.015", "PMC7201239", "32414646"]}, {"Citation": "Tahir ul Qamar M, Alqahtani SM, Alamri MA, Chen LL. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. (in press) 10.20944/preprints202002.0193.v1", "ArticleIdList": ["10.20944/preprints202002.0193.v1", "PMC7156227", "32296570"]}, {"Citation": "Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, et al. . Structural basis of receptor recognition by SARS-CoV-2. Nature. (2020) 581:221\u20134. 10.1038/s41586-020-2179-y", "ArticleIdList": ["10.1038/s41586-020-2179-y", "PMC7328981", "32225175"]}, {"Citation": "Hilgenfeld R. From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J. (2014) 281:4085\u201396. 10.1111/febs.12936", "ArticleIdList": ["10.1111/febs.12936", "PMC7163996", "25039866"]}, {"Citation": "Zeng Q, Langereis MA, van Vliet ALW, Huizinga EG, de Groot RJ. Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution. Proc Natl Acad Sci USA. (2008) 105:9065\u20139. 10.1073/pnas.0800502105", "ArticleIdList": ["10.1073/pnas.0800502105", "PMC2449365", "18550812"]}, {"Citation": "Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. (2020) 1843\u201344. 10.1001/jama.2020.3786", "ArticleIdList": ["10.1001/jama.2020.3786", "PMC7066521", "32159775"]}, {"Citation": "Saxena SK, Kumar S, Maurya VK, Sharma R, Dandu HR, Bhatt MLB. Current insight into the novel coronavirus disease 2019 (COVID-19). Nat Public Health Emerg Collect. (2020) 2019:1\u20138. 10.1007/978-981-15-4814-7_1", "ArticleIdList": ["10.1007/978-981-15-4814-7", "0"]}, {"Citation": "Liu C, Zhou Q, Li Y, Garner LV, Watkins SP, Carter LJ, et al. . Research and development on therapeutic agents and vaccines for covid-19 and related human coronavirus diseases. ACS Cent Sci. (2020) 6:315\u201331. 10.1021/acscentsci.0c00272", "ArticleIdList": ["10.1021/acscentsci.0c00272", "PMC10467574", "32226821"]}, {"Citation": "Salata C, Calistri A, Parolin C, Pal\u00f9 G. Coronaviruses: a paradigm of new emerging zoonotic diseases. Pathog Dis. (2020) 77:ftaa006. 10.1093/femspd/ftaa006", "ArticleIdList": ["10.1093/femspd/ftaa006", "PMC7108526", "32065221"]}, {"Citation": "Wilder-smith A, Chiew CJ, Lee VJ. Can we contain the COVID-19 outbreak with the same measures as for SARS? Lancet Infect Dis. (2020) 20:e102\u20137. 10.1016/S1473-3099(20)30129-8", "ArticleIdList": ["10.1016/S1473-3099(20)30129-8", "PMC7102636", "32145768"]}, {"Citation": "Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. (2020) 19:149\u201350. 10.1038/d41573-020-00016-0", "ArticleIdList": ["10.1038/d41573-020-00016-0", "32127666"]}, {"Citation": "Andersen PI, Ianevski A, Lysvand H, Vitkauskiene A, Oksenych V, Bj\u00f8r\u00e5s M, et al. . Discovery and development of safe-in-man broad-spectrum antiviral agents. Int J Infect Dis. (2020) 93:268\u201376. 10.1016/j.ijid.2020.02.018", "ArticleIdList": ["10.1016/j.ijid.2020.02.018", "PMC7128205", "32081774"]}, {"Citation": "Liu M, Yu Q, Xiao H, Yi Y, Cheng H, Putra DF, et al. . Antiviral activity of Illicium verum Hook. f. extracts against grouper iridovirus infection. J Fish Dis. (2020) 43:531\u201340. 10.1111/jfd.13146", "ArticleIdList": ["10.1111/jfd.13146", "32100315"]}, {"Citation": "Fuzimoto AD, Isidoro C. The antiviral and the coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - additional weapons in the fight against the COVID-19 pandemic? J Tradit Complement Med. (2020) 10:405\u201319. 10.1016/j.jtcme.2020.05.003", "ArticleIdList": ["10.1016/j.jtcme.2020.05.003", "PMC7260130", "32691005"]}, {"Citation": "Chen L, Xiong J, Bao L, Shi Y. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis. (2020) 20:398\u2013400. 10.1016/S1473-3099(20)30141-9", "ArticleIdList": ["10.1016/S1473-3099(20)30141-9", "PMC7128218", "32113510"]}, {"Citation": "Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. (2020) 20:269\u201370. 10.1038/s41577-020-0308-3", "ArticleIdList": ["10.1038/s41577-020-0308-3", "PMC7143200", "32273594"]}, {"Citation": "Vankadari N. Arbidol: a potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein. Int J Antimicrob Agents. (2020) 28:105998. 10.1016/j.ijantimicag.2020.105998", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105998", "PMC7187825", "32360231"]}, {"Citation": "Khan SA, Zia K, Ashraf S, Uddin R, Ul-Haq Z. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. J Biomol Struct Dyn. (2020) 2020:1\u201310. 10.1080/07391102.2020.1751298", "ArticleIdList": ["10.1080/07391102.2020.1751298", "32238094"]}, {"Citation": "Delang L, Abdelnabi R, Neyts J. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses. Antiviral Res. (2018) 153:85\u201394. 10.1016/j.antiviral.2018.03.003", "ArticleIdList": ["10.1016/j.antiviral.2018.03.003", "29524445"]}, {"Citation": "Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. (2020) 30:269\u201371. 10.1038/s41422-020-0282-0", "ArticleIdList": ["10.1038/s41422-020-0282-0", "PMC7054408", "32020029"]}, {"Citation": "Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. (2020) 178:3\u20136. 10.1016/j.antiviral.2020.104787", "ArticleIdList": ["10.1016/j.antiviral.2020.104787", "PMC7129059", "32251768"]}, {"Citation": "Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. . A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19. N Engl J Med. (2020) 382:1787\u201399. 10.1056/NEJMc2008043", "ArticleIdList": ["10.1056/NEJMc2008043", "PMC7121492", "32187464"]}, {"Citation": "Elmezayen AD, Al-Obaidi A, Sahin AT, Yelek\u00e7i K. Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. J Biomol Struct Dyn. (2020) 2020:1\u201313. 10.1080/07391102.2020.1758791", "ArticleIdList": ["10.1080/07391102.2020.1758791", "PMC7189413", "32306862"]}, {"Citation": "Muralidharan N, Sakthivel R, Velmurugan D, Gromiha MM. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. J Biomol Struct Dyn. (2020) 2020:1\u20136. 10.1080/07391102.2020.1752802", "ArticleIdList": ["10.1080/07391102.2020.1752802", "32248766"]}, {"Citation": "Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. (2020) 14:58\u201360. 10.5582/ddt.2020.01012", "ArticleIdList": ["10.5582/ddt.2020.01012", "32147628"]}, {"Citation": "Sarma P, Sekhar N, Prajapat M, Avti P, Kaur H, Kumar S, et al. . In-silico homology assisted identification of inhibitors of RNA binding against 2019-nCoV N-protein (N terminal domain). J Biomol Struct Dyn. (2020) 2020:1\u20139. 10.1080/07391102.2020.1753580", "ArticleIdList": ["10.1080/07391102.2020.1753580", "PMC7256351", "32266867"]}, {"Citation": "Baron SA, Devaux C, Colson P, Raoult D, Rolain JM. Teicoplanin: an alternative drug for the treatment of COVID-19? Int J Antimicrob Agents. (2020) 55:105944. 10.1016/j.ijantimicag.2020.105944", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105944", "PMC7102624", "32179150"]}, {"Citation": "Enmozhi SK, Raja K, Sebastine I, Joseph J. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. J Biomol Struct Dyn. (2020) 2020:1\u20137. 10.1080/07391102.2020.1760136", "ArticleIdList": ["10.1080/07391102.2020.1760136", "PMC7212536", "32329419"]}, {"Citation": "Peng S, Li Z, Zou L, Liu W, Liu C, McClements DJ. Enhancement of curcumin bioavailability by encapsulation in Sophorolipid-coated nanoparticles: an in vitro and in vivo study. Agric Food Chem. (2018) 66:1488\u201397. 10.1021/acs.jafc.7b05478", "ArticleIdList": ["10.1021/acs.jafc.7b05478", "29378117"]}, {"Citation": "Wu R, Wang L, Kuo HCD, Shannar A, Peter R, Chou PJ, et al. . An update on current therapeutic drugs treating COVID-19. Curr Pharmacol Rep. (2020) 11:1\u201315. 10.1007/s40495-020-00216-7", "ArticleIdList": ["10.1007/s40495-020-00216-7", "PMC7211915", "32395418"]}, {"Citation": "Maurya VK, Kumar S, Bhatt MLB, Saxena SK. Therapeutic development and drugs for the treatment of COVID-19. Nat Public Health Emerg Collect. (2020) 2019:109\u201326. 10.1007/978-981-15-4814-7_10", "ArticleIdList": ["10.1007/978-981-15-4814-7"]}, {"Citation": "Koparde AA, Doijad RC, Magdum CS, Koparde AA. Natural products in drug discovery. In: Doijad RC, editor. Pharmacognosy - Medicinal Plants. Rijeka: IntechOpen; (2019). p. 14 10.5772/intechopen.82860", "ArticleIdList": ["10.5772/intechopen.82860"]}, {"Citation": "Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Neurol. (2014) 4:177. 10.3389/fphar.2013.00177", "ArticleIdList": ["10.3389/fphar.2013.00177", "PMC3887317", "24454289"]}, {"Citation": "Ganjhu RK, Mudga PP, Maity H, Dowarha D, Devadiga S, Nag S, et al. . Herbal plants and plant preparations as a remedial approach for viral diseases. Virus Dis. (2015) 26:225\u201336. 10.1007/s13337-015-0276-6", "ArticleIdList": ["10.1007/s13337-015-0276-6", "PMC4663710", "26645032"]}, {"Citation": "Chitemerere TA, Mukanganyama S. Evaluation of cell membrane integrity as a potential antimicrobial target for plant products. BMC Complement Altern Med. (2014) 14:278. 10.1186/1472-6882-14-278", "ArticleIdList": ["10.1186/1472-6882-14-278", "PMC4124163", "25078023"]}, {"Citation": "Anandhi D, Srinivasan PT, Kumar GP, Jagatheesh S. Original research article DNA fragmentation induced by the glycosides and flavonoids from C. coriaria. Int J Curr Microbiol App Sci. (2014) 3:666\u201373."}, {"Citation": "Zhao X, Zhao F, Zhong N. Quorum sensing inhibition and anti-biofilm activity of traditional Chinese medicine. In: El-Samragy Y, editor. Food Safety - Some Global Trends. Itratech Open; (2018). p. 14 10.5772/intechopen.74658", "ArticleIdList": ["10.5772/intechopen.74658"]}, {"Citation": "Radulovic NS, Blagojevic PD, Stojanovic-Radic ZZ, Stojanovic NM. Antimicrobial plant metabolites: structural diversity and mechanism of action. Curr Med Chem. (2013) 20:932\u201352. 10.2174/0929867311320070008", "ArticleIdList": ["10.2174/0929867311320070008", "23210781"]}, {"Citation": "Mogosanu GD, Grumezescu AM, Huang KS, Bejenaru LE, Bejenaru C. Prevention of microbial communities: novel approaches based natural products. Curr Pharm Biotechnol. (2015) 16:94\u2013111. 10.2174/138920101602150112145916", "ArticleIdList": ["10.2174/138920101602150112145916", "25594287"]}, {"Citation": "Anand U, Jacobo-Herrera N, Altemimi A, Lakhssassi N. A comprehensive review on medicinal plants as antimicrobial therapeutics: potential avenues of biocompatible drug discovery. Metabolites. (2019) 9:258. 10.3390/metabo9110258", "ArticleIdList": ["10.3390/metabo9110258", "PMC6918160", "31683833"]}, {"Citation": "Zhang D, Wu K, Zhang X, Deng S, Peng B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J Integr Med. (2020) 18:152\u20138. 10.1016/j.joim.2020.02.005", "ArticleIdList": ["10.1016/j.joim.2020.02.005", "PMC7102521", "32113846"]}, {"Citation": "Kiran G, Karthik L, Shree Devi MS, Sathiyarajeswaran P, Kanakavalli K, Kumar KM, et al. . In silico computational screening of Kabasura Kudineer - official Siddha Formulation and JACOM against SARS-CoV-2 spike protein. J Ayurveda Integr Med. (in press) 10.1016/j.jaim.2020.05.009", "ArticleIdList": ["10.1016/j.jaim.2020.05.009", "PMC7247487", "32527713"]}, {"Citation": "Subbaiyan A, Ravichandran K, Singh SV, Sankar M, Thomas P, Dhama K, et al. In silico molecular docking analysis targeting SARS-CoV-2 spike protein and selected herbal constituents. J Pure Appl Microbiol. (2020) 14:989\u201398. 10.22207/JPAM.14.SPL1.37", "ArticleIdList": ["10.22207/JPAM.14.SPL1.37"]}, {"Citation": "Nivetha R, Bhuvaragavan S, Janarthanan S. Inhibition of multiple SARS-CoV-2 proteins by an antiviral biomolecule, seselin from Aegle marmelos deciphered using molecular docking analysis. Res Sq. (2020) 2020:v1 10.21203/rs.3.rs-31134/v1", "ArticleIdList": ["10.21203/rs.3.rs-31134/v1", "34431451"]}, {"Citation": "Basu A, Sarkar A, Maulik U. Computational approach for the design of potential spike protein binding natural compounds in SARS- CoV2. Pharmacodynamics. (2020). 10.21203/rs.3.rs-33181/v1. [Epub ahead of print].", "ArticleIdList": ["10.21203/rs.3.rs-33181/v1."]}, {"Citation": "Krishnasamy R, Anand T, Baba M, Bharath MV, Phuntsho J, Arunachalam D, et al. In silico analysis of active compounds from siddha herbal infusion of Ammaiyar Koondhal Kudineer (Akk) against SARS-CoV-2 spike protein and its ACE2 receptor complex. SSRN Online J. (2020). 10.2139/ssrn.3578294. [Epub ahead of print].", "ArticleIdList": ["10.2139/ssrn.3578294."]}, {"Citation": "Pandit M, Latha N. In silico studies reveal potential antiviral activity of phytochemicals from medicinal plants for the treatment of COVID-19 infection. Res Sq. (2020). 10.21203/rs.3.rs-22687/v1. [Epub ahead of print].", "ArticleIdList": ["10.21203/rs.3.rs-22687/v1."]}, {"Citation": "Pandeya KB, Ganeshpurkar A, Kumar Mishra M. Natural RNA dependent RNA polymerase inhibitors: molecular docking studies of some biologically active alkaloids of Argemone mexicana. Med Hypotheses. (2020) 2020:109905 10.1016/j.mehy.2020.109905", "ArticleIdList": ["10.1016/j.mehy.2020.109905", "PMC7262531", "32535456"]}, {"Citation": "Aanouz I, Belhassan A, El-Khatabi K, Lakhlifi T, El-ldrissi M, Bouachrine M. Moroccan medicinal plants as inhibitors against SARS-CoV-2 main protease: computational investigations. J Biomol Struct Dyn. (2020) 2020:1\u20139. 10.1080/07391102.2020.1758790", "ArticleIdList": ["10.1080/07391102.2020.1758790", "PMC7212546", "32306860"]}, {"Citation": "Bhardwaj VK, Singh R, Sharma J, Rajendran V, Purohit R, Kumar S. Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. J Biomol Struct Dyn. (2020) 2020:1\u201311. 10.1080/07391102.2020.1766572", "ArticleIdList": ["10.1080/07391102.2020.1766572", "PMC7256349", "32397940"]}, {"Citation": "Serseg T, Benarous K, Yousfi M. Hispidin and Lepidine E: two natural compounds and folic acid as potential inhibitors of 2019-novel coronavirus main protease (2019-nCoVMpro), molecular docking and SAR study. Curr Comput Aided Drug Des. (2020). 10.2174/1573409916666200422075440. [Epub ahead of print].", "ArticleIdList": ["10.2174/1573409916666200422075440.", "32321407"]}, {"Citation": "Kumar A, Choudhir G, Shukla SK, Sharma M, Tyagi P, Bhushan A, et al. . Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. J Biomol Struct Dyn. (2020) 2020:1\u201311. 10.21203/rs.3.rs-31210/v1", "ArticleIdList": ["10.21203/rs.3.rs-31210/v1", "PMC7284142", "32448034"]}, {"Citation": "Islam MT, Sarkar C, El-Kersh DM, Jamaddar S, Uddin SJ, Shilpi JA, et al. . Natural products and their derivatives against coronavirus: a review of the non-clinical and pre-clinical data. Phyther Res. (2020). 10.1002/ptr.6700", "ArticleIdList": ["10.1002/ptr.6700", "32248575"]}, {"Citation": "Sayed AM, Khattab AR, AboulMagd AM, Hassan HM, Rateb ME, Zaid H, et al. Nature as a treasure trove of potential anti-SARS-CoV drug leads: a structural/mechanistic rationale. RSC Adv. (2020) 10:19790\u2013802. 10.1039/D0RA04199H", "ArticleIdList": ["10.1039/D0RA04199H", "PMC9122629", "35685913"]}, {"Citation": "Sepay N, Sepay N, Al Hoque A, Mondal R, Halder UC, Muddassir M. In silico fight against novel coronavirus by finding chromone derivatives as inhibitor of coronavirus main proteases enzyme. Struct Chem. (2020) 2020:1\u201310. 10.1007/s11224-020-01537-5", "ArticleIdList": ["10.1007/s11224-020-01537-5", "PMC7220622", "32412544"]}, {"Citation": "Umesh U, Kundu D, Selvaraj C, Singh SK, Dubey VK. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target. J Biomol Struct Dyn. (2020) 2020:1\u20139. 10.1080/07391102.2020.1763202", "ArticleIdList": ["10.1080/07391102.2020.1763202", "PMC7232883", "32362243"]}, {"Citation": "Singh A, Mishra A. Leucoefdin a potential inhibitor against SARS CoV-2 M. J Biomol Struct Dyn. (2020) 2020:1\u20136. 10.1080/07391102.2020.1777903", "ArticleIdList": ["10.1080/07391102.2020.1777903", "PMC7309301", "34281489"]}, {"Citation": "Gupta MK, Vemula S, Donde R, Gouda G, Behera L, Vadde R. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. J Biomol Struct Dyn. (2020) 2020:1\u201311. 10.1080/07391102.2020.1751300", "ArticleIdList": ["10.1080/07391102.2020.1751300", "PMC7171389", "32238078"]}, {"Citation": "Joshi RS, Jagdale SS, Bansode SB, Shankar SS, Tellis MB, Pandya VK, et al. . Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. J Biomol Struct Dyn. (2020) 2020:1\u20136. 10.20944/preprints202004.0068.v2", "ArticleIdList": ["10.20944/preprints202004.0068.v2", "PMC7212545", "32329408"]}, {"Citation": "Joshi T, Joshi T, Sharma P, Mathpal S, Pundir H, Bhatt V, et al. . In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking. Eur Rev Med Pharmacol Sci. (2020) 24:4529\u201336. 10.26355/eurrev_202004_21036", "ArticleIdList": ["10.26355/eurrev", "32373991"]}, {"Citation": "Salman S, Shah FH, Idrees J, Idrees F, Velagala S, Ali J, et al. Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-COV-2 inhibitors. Future Virol. (2020). 10.2217/fvl-2020-0079. [Epub ahead of print].", "ArticleIdList": ["10.2217/fvl-2020-0079."]}, {"Citation": "Wahedi HM, Ahmad S, Abbasi SW. Stilbene-based natural compounds as promising drug candidates against COVID-19. J Biomol Struct Dyn. (2020) 2020:1\u201310. 10.1080/07391102.2020.1762743", "ArticleIdList": ["10.1080/07391102.2020.1762743", "32345140"]}, {"Citation": "Abdelli I, Hassani F, Bekkel Brikci S, Ghalem S. In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria. J Biomol Struct Dyn. (2020) 2020:1\u201314. 10.1080/07391102.2020.1763199", "ArticleIdList": ["10.1080/07391102.2020.1763199", "PMC7232889", "32362217"]}, {"Citation": "Murugan NA, Pandian CJ, Jeyakanthan J. Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials. J Biomol Struct Dyn. (2020) 2020:1\u201312. 10.1080/07391102.2020.1777901", "ArticleIdList": ["10.1080/07391102.2020.1777901", "PMC7309306", "32543978"]}, {"Citation": "Gyebi GA, Ogunro OB, Adegunloye AP, Ogunyemi OM, Afolabi SO. Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and Terpenoids from African medicinal plants. J Biomol Struct Dyn. (2020) 20201\u201313. 10.1080/07391102.2020.1764868", "ArticleIdList": ["10.1080/07391102.2020.1764868", "PMC7256353", "32367767"]}, {"Citation": "Sampangi-Ramaiah MH, Vishwakarma R, Shaanker RU. Molecular docking analysis of selected natural products from plants for inhibition of SARS-CoV-2 main protease. Curr Sci. (2020) 118:1087\u201392."}, {"Citation": "Kumar V, Dhanjal JK, Bhargava P, Kaul A, Wang J, Zhang H, et al. . Withanone and withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. J Biomol Struct Dyn. (2020) 2020:1\u201313. 10.1080/07391102.2020.1775704", "ArticleIdList": ["10.1080/07391102.2020.1775704", "PMC7309304", "32469279"]}, {"Citation": "Borkotoky S, Banerjee M. A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem). J Biomol Struct Dyn. (2020) 2020:1\u20137. 10.1080/07391102.2020.1774419", "ArticleIdList": ["10.1080/07391102.2020.1774419", "PMC7311162", "32462988"]}, {"Citation": "Elfiky AA. Natural products may interfere with SARS-CoV-2 attachment to the host cell. J Biomol Struct Dyn. (2020) 2020:1\u201310. 10.21203/rs.3.rs-22458/v1", "ArticleIdList": ["10.21203/rs.3.rs-22458/v1", "PMC7212544", "32340551"]}, {"Citation": "Ahmad S, Abbasi HW, Shahid S, Gul S, Abbasi SW. Molecular docking, simulation and MM-PBSA studies of nigella sativa compounds: a computational quest to identify potential natural antiviral for COVID-19 treatment. J Biomol Struct Dyn. (2020) 2020:1\u20139. 10.1080/07391102.2020.1775129", "ArticleIdList": ["10.1080/07391102.2020.1775129", "PMC7298883", "32462996"]}, {"Citation": "Saito K. Phytochemical genomics-a new trend. Curr Opin Plant Biol. (2013) 16:373\u201380. 10.1016/j.pbi.2013.04.001", "ArticleIdList": ["10.1016/j.pbi.2013.04.001", "23628002"]}, {"Citation": "Mathur S, Hoskins C. Drug development: lessons from nature. Biomed Rep. (2017) 6:612\u20134. 10.3892/br.2017.909", "ArticleIdList": ["10.3892/br.2017.909", "PMC5449954", "28584631"]}, {"Citation": "Wink M. Plant secondary metabolites modulate insect behavior-steps toward addiction? Front Physiol. (2018) 9:364. 10.3389/fphys.2018.00364", "ArticleIdList": ["10.3389/fphys.2018.00364", "PMC5904355", "29695974"]}, {"Citation": "Ebenezer KS, Manivannan R, Punniyamoorthy A, Tamilselvan C. Plant secondary metabolites of antiviral properties a rich medicinal source for drug discovery: a mini review. J Drug Deliv Ther. (2019) 9:161\u20137. 10.22270/jddt.v9i5.3471", "ArticleIdList": ["10.22270/jddt.v9i5.3471"]}, {"Citation": "Calixto JB. The role of natural products in modern drug discovery. An Acad Bras Cienc. (2019) 91:20190105. 10.1590/0001-3765201920190105", "ArticleIdList": ["10.1590/0001-3765201920190105", "31166478"]}, {"Citation": "Hardman WE. Diet components can suppress inflammation and reduce cancer risk. Nutr Res Prac.t. (2014) 8:233\u201340. 10.4162/nrp.2014.8.3.233", "ArticleIdList": ["10.4162/nrp.2014.8.3.233", "PMC4058555", "24944766"]}, {"Citation": "Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P, et al. . Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv. (2015) 33:1582\u2013614. 10.1016/j.biotechadv.2015.08.001", "ArticleIdList": ["10.1016/j.biotechadv.2015.08.001", "PMC4748402", "26281720"]}, {"Citation": "Annunziata G, Sanduzzi Zamparelli M, Santoro C, Ciampaglia R, Stornaiuolo M, Tenore GC, et al. . May polyphenols have a role against coronavirus infection? An overview of in vitro evidence. Front Med. (2020) 7:240. 10.3389/fmed.2020.00240", "ArticleIdList": ["10.3389/fmed.2020.00240", "PMC7243156", "32574331"]}, {"Citation": "Chowdhury P, Sahuc M, Rouill\u00e9 C, Rivi\u00e8re C, Bonneau N, Vandeputte A, et al. . Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture. PLoS ONE. (2018) 13:11. 10.1371/journal.pone.0198226", "ArticleIdList": ["10.1371/journal.pone.0198226", "PMC6261387", "30485282"]}, {"Citation": "V\u00e1zquez-Calvo \u00c1, Oya N, Mart\u00edn-Acebes MA, Garcia-Moruno E, Saiz J. Antiviral properties of the natural polyphenols delphinidin and epigallocatechin gallate against the flaviviruses West Nile virus, Zika virus, and dengue virus. Front Microbiol. (2017) 8:1314. 10.3389/fmicb.2017.01314", "ArticleIdList": ["10.3389/fmicb.2017.01314", "PMC5504193", "28744282"]}, {"Citation": "Park JY, Yuk HJ, Ryu HW, Lim SH, Kim KS, Park KH, et al. . Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. J Enzyme Inhib Med Chem. (2017) 32:504\u201312. 10.1080/14756366.2016.1265519", "ArticleIdList": ["10.1080/14756366.2016.1265519", "PMC6010046", "28112000"]}, {"Citation": "Abdelmageed MI, Abdelmoneim AH, Mustafa MI, Elfadol NM, Murshed NS, Shantier SW, et al. . Design of a multiepitope-based peptide vaccine against the E protein of human COVID-19: an immunoinformatics approach. BioMed Res Int. (2020) 2020:2683286. 10.1101/2020.02.04.934232", "ArticleIdList": ["10.1101/2020.02.04.934232", "PMC7212276", "32461973"]}, {"Citation": "Ghosh R, Chakraborty A, Biswas A, Chowdhuri S. Evaluation of green tea polyphenols as novel coronavirus (SARS CoV-2) main protease (Mpro) inhibitors \u2013 an in silico docking and molecular dynamics simulation study. J Biomol Struct Dyn. (2020) 1\u201311. 10.1080/07391102.2020.1779818", "ArticleIdList": ["10.1080/07391102.2020.1779818", "PMC7332865", "32568613"]}, {"Citation": "Jo S, Kim S, Shin DH, Kim MS. Inhibition of SARS-CoV 3CL protease by flavonoids. J Enzyme Inhib Med Chem. (2020) 35:145\u201351. 10.1080/14756366.2019.1690480", "ArticleIdList": ["10.1080/14756366.2019.1690480", "PMC6882434", "31724441"]}, {"Citation": "Peterson L. In silico molecular dynamics docking of drugs to the inhibitory active site of SARS-CoV-2 protease and their predicted toxicology and ADME. SSRN Electron J. (2020). 10.26434/chemrxiv.12155523.v1", "ArticleIdList": ["10.26434/chemrxiv.12155523.v1"]}, {"Citation": "Owis A, Marwa EH, Dalia EA, Omar A, Usama A, Mohamed K. Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease. RSC Adv. (2020) 10:19570\u201375. 10.1039/D0RA03582C", "ArticleIdList": ["10.1039/D0RA03582C", "PMC9054211", "35515460"]}, {"Citation": "Thawabteh A, Juma S, Bader M, Karaman D, Scrano L, Bufo SA, et al. . The biological activity of natural alkaloids against herbivores, cancerous cells and pathogens. Toxins. (2019) 11:656\u201383. 10.3390/toxins11110656", "ArticleIdList": ["10.3390/toxins11110656", "PMC6891610", "31717922"]}, {"Citation": "Kim DE, Min JS, Jang MS, Lee JY, Shin YS, Park CM, et al. . Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus oc43 infection of mrc-5 human lung cells. Biomolecules. (2019) 9:696. 10.3390/biom9110696", "ArticleIdList": ["10.3390/biom9110696", "PMC6921063", "31690059"]}, {"Citation": "Wink M. Potential of DNA intercalating alkaloids and other plant secondary metabolites against SARS-CoV-2 causing COVID-19. Diversity. (2020) 12:175 10.3390/d12050175", "ArticleIdList": ["10.3390/d12050175"]}, {"Citation": "Colson P, Rolain J, Roult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. (2020) 55:105923 10.1016/j.ijantimicag.2020.105923", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105923", "PMC7134866", "32070753"]}, {"Citation": "Hussein RA, El-Anssary AA. Plants secondary metabolites: the key drivers of the pharmacological actions of medicinal plants. Herb Med. (2019) 10.5772/intechopen.76139", "ArticleIdList": ["10.5772/intechopen.76139"]}, {"Citation": "Wen CC, Kuo YH, Jan JT, Liang PH, Wang SY, Liu HG, et al. . Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem. (2007) 50:4087\u201395. 10.1021/jm070295s", "ArticleIdList": ["10.1021/jm070295s", "17663539"]}, {"Citation": "\u00c1lvarez DM, Castillo E, Duarte LF, Arriagada J, Corrales N, Far\u00edas MA, et al. . Current antivirals and novel botanical molecules interfering with herpes simplex virus infection. Front Microbiol. (2020) 11:139. 10.3389/fmicb.2020.00139", "ArticleIdList": ["10.3389/fmicb.2020.00139", "PMC7026011", "32117158"]}, {"Citation": "Sun Z, Yu C, Wang W, Yu G, Zhang T, Zhang L, et al. . Aloe polysaccharides inhibit Influenza A virus infection\u2014a promising natural anti-flu drug. Front Microbiol. (2018) 9:2338. 10.3389/fmicb.2018.02338", "ArticleIdList": ["10.3389/fmicb.2018.02338", "PMC6170609", "30319596"]}, {"Citation": "Mera IFG, Falcon\u00ed DEG, C\u00f3rdova VM. Secondary metabolites in plants: main classes, phytochemical analysis and pharmacological activities. Rev Bionatura. (2019) 4:1000\u20139. 10.21931/RB/2019.04.04.11", "ArticleIdList": ["10.21931/RB/2019.04.04.11"]}, {"Citation": "Strovel J, Sittampalam S, Coussens NP, Hughes M, Inglese J, Kurtz A, et al. . Early Drug Discovery and Development Guidelines: for Academic Researchers, Collaborators, and Start-Up Companies. Assay Guidance Manual. Bethesda, MD: Eli Lilly & Company and the National Center for Advancing Translational Sciences; (2004). p. 1\u201335.", "ArticleIdList": ["22553881"]}, {"Citation": "Kr\u00fcger A, Gon\u00e7alves Maltarollo V, Wrenger C, Kronenberger T. ADME profiling in drug discovery and a new path paved on silica. In: Gaitonde V, editor. Drug Discovery and Development - New Advances. Itratech open; (2020). p. 32 10.5772/intechopen.86174", "ArticleIdList": ["10.5772/intechopen.86174"]}, {"Citation": "Seca AML, Pinto DCGA. Biological potential and medical use of secondary metabolites. Medicines. (2019) 6:66. 10.3390/medicines6020066", "ArticleIdList": ["10.3390/medicines6020066", "PMC6632032", "31212776"]}, {"Citation": "Dias DA, Urban S, Roessner U. A historical overview of natural products in drug discovery. Metabolites. (2012) 2:303\u201336. 10.3390/metabo2020303", "ArticleIdList": ["10.3390/metabo2020303", "PMC3901206", "24957513"]}, {"Citation": "Anand U, Nandy S, Mundhra A, Das N, Pandey DK, Dey A. A review on antimicrobial botanicals, phytochemicals and natural resistance modifying agents from Apocynaceae family: possible therapeutic approaches against multidrug resistance in pathogenic microorganisms. Drug Resist Update. (2020) 51:100695. 10.1016/j.drup.2020.100695", "ArticleIdList": ["10.1016/j.drup.2020.100695", "32442892"]}, {"Citation": "Anwar N, Teo Y, Joash T. The role of plant metabolites in drug discovery: current challenges and future perspectives. In: Swamy MK, Akhtar MS. editors. Natural Bio-active Compounds, Volume 2: Chemistry, Pharmacology and Health Care Practices. New York, NY: Springer Publications; (2019). p. 25\u201351. 10.1007/978-981-13-7205-6_2", "ArticleIdList": ["10.1007/978-981-13-7205-6_2"]}, {"Citation": "Gonzalez-Alfonso JL, Pe\u00f1alver P, Ballesteros AO, Morales JC, Plou FJ. Effect of \u03b1-Glycosylation on the stability, antioxidant properties, toxicity, and neuroprotective activity of (-)-Epigallocatechin gallate. Front Nutr. (2019) 6:30 10.3389/fnut.2019.00030", "ArticleIdList": ["10.3389/fnut.2019.00030", "PMC6438877", "30968027"]}, {"Citation": "Sharifi-Rad M, Pezzani R, Redaelli M, Zorzan M, Imran M, Khalil AA, et al. . Preclinical pharmacological activities of Epigallocatechin-3-gallate in signaling pathways: an update on cancer. Molecules. (2020) 25:467. 10.3390/molecules25030467", "ArticleIdList": ["10.3390/molecules25030467", "PMC7037968", "31979082"]}, {"Citation": "Banerjee A, Czinn SJ, Reiter RJ, Blanchard TG. Crosstalk between endoplasmic reticulum stress and anti-viral activities: a novel therapeutic target for COVID-19. Life Sci. (2020) 255:117842. 10.1016/j.lfs.2020.117842", "ArticleIdList": ["10.1016/j.lfs.2020.117842", "PMC7245231", "32454157"]}, {"Citation": "Karade PG, Jadhav NR. Colon targeted curcumin microspheres laden with ascorbic acid for bioavailability enhancement. J Microencapsul. (2018) 35:372\u201380. 10.1080/02652048.2018.1501111", "ArticleIdList": ["10.1080/02652048.2018.1501111", "30010458"]}, {"Citation": "Azim KF, Ahmed SR, Banik A, Khan MMR, Deb A, Somana SR. Screening and druggability analysis of some plant metabolites against SARS-CoV-2: an integrative computational approach. Inform Med Unlocked. (2020) 20:100367. 10.1016/j.imu.2020.100367", "ArticleIdList": ["10.1016/j.imu.2020.100367", "PMC7280834", "32537482"]}, {"Citation": "Capell T, Twyman RM, Armario NV, Ma JKC, Schillberg S, Christou P. Potential applications of plant biotechnology against SARS-CoV-2. Trends Plant Sci. (2020) 25:635\u201343. 10.1016/j.tplants.2020.04.009", "ArticleIdList": ["10.1016/j.tplants.2020.04.009", "PMC7181989", "32371057"]}, {"Citation": "Nakabayashi R, Saito K. Metabolomics for unknown plant metabolites. Anal Bioanal Chem. (2013) 405:5005\u201311. 10.1007/s00216-013-6869-2", "ArticleIdList": ["10.1007/s00216-013-6869-2", "23532390"]}, {"Citation": "Li D Halitschke R Baldwin IT Gaquerel E . Information theory tests critical predictions of plant defense theory for specialized metabolism. Sci Adv. (2020) 6:eaaz0381. 10.1126/sciadv.aaz0381", "ArticleIdList": ["10.1126/sciadv.aaz0381", "PMC7286674", "32577508"]}, {"Citation": "Bhuiyan FR, Campos NA, Swennen R, Carpentier S. Characterizing fruit ripening in plantain and Cavendish bananas: a proteomics approach. J Proteomics. (2020) 214:103632. 10.1016/j.jprot.2019.103632", "ArticleIdList": ["10.1016/j.jprot.2019.103632", "31891784"]}, {"Citation": "Runfeng L, Yunlong H, Jicheng H, Weiqi P, Qinhai M, Yongxia S, et al. . Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol Res. (2020) 156:104761. 10.1016/j.phrs.2020.104761", "ArticleIdList": ["10.1016/j.phrs.2020.104761", "PMC7102548", "32205232"]}, {"Citation": "Cyranoski D. China is promoting coronavirus treatments based on unproven traditional medicines. Nature. (2020). 10.1038/d41586-020-01284-x. [Epub ahead of print].", "ArticleIdList": ["10.1038/d41586-020-01284-x.", "32376938"]}, {"Citation": "Nguyen-Vo TH, Nguyen L, Do N, Nguyen TN, Trinh K, Cao H, et al. . Plant metabolite databases: from herbal medicines to modern drug discovery. J Chem Inf Model. (2020) 60:1101\u201310. 10.1021/acs.jcim.9b00826", "ArticleIdList": ["10.1021/acs.jcim.9b00826", "31873010"]}, {"Citation": "Johnson SR, Lange BM. Open-access metabolomics databases for natural product research: present capabilities and future potential. Front Bioeng Biotechnol. (2015) 3:22. 10.3389/fbioe.2015.00022", "ArticleIdList": ["10.3389/fbioe.2015.00022", "PMC4349186", "25789275"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "4", "Day": "14"}, {"Year": "2020", "Month": "7", "Day": "6"}, {"Year": "2020", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "8", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["32850918", "PMC7427128", "10.3389/fmed.2020.00444"]}}], "PubmedBookArticle": []}